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Ribonucleic acid (RNA) has the ability to store and transfer genetic information, and also 
to catalyze chemical reactions.  This observation has led to the RNA world hypothesis, which 
states that there was likely a time in early evolution (before DNA and proteins) in which RNA 
carried out both these functions.  In particular, RNA may have played an important role in the 
origin of protein (peptide) synthesis, or translation.  While modern protein synthesis requires 
protein catalysis or stabilization at each of the relevant chemical steps, RNA is the functional 
heart of the ribosome.  There must have been a mechanism in place to synthesize the first 
proteins, which logically could not have been protein-catalyzed.  Early proteins, then, may have 
been synthesized by RNA catalysts.   
Most previously characterized RNA enzymes, or ribozymes, are relatively complex.  This 
makes their existence in the early RNA world problematic, since even RNA synthesis must have 
been relatively inefficient.  In this work, I show that a ribozyme that is only five nucleotides long 
can catalyze one of the reactions relevant to protein synthesis, aminoacylation of an RNA 
substrate, using the same reactants that biology uses today.  In addition, this ribozyme/substrate 
complex hosts the formation of RNA-peptides and aminoacyl- and peptidyl-RNA diesters.   
In addition, no ribozymes have been found which catalyze the final crucial step of protein 
synthesis, peptide bond formation.  I approach this problem by showing that RNAs that bind 
specifically to a dipeptide can be derived through in vitro selection.  Therefore, RNAs can bind 
iv 
to two amino acids simultaneously.  This observation strengthens the argument that the first 
peptides could have formed from specific, direct interactions between amino acids and RNA. 
The conclusion of this work is that small RNAs may have served important functions in 
the origin of translation during the RNA world.  The formation of an ester bond between an 
amino acid and an RNA molecule can be catalyzed by RNA with very little sequence 
information.  Moreover, I show that the RNA can interact specifically not just with individual 
amino acids, but also with multiple amino acids.  This may provide an explanation for how the 
first coded peptides formed in the absence of protein catalysts. 
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CHAPTER I 
INTRODUCTION 
 
Background 
Catalytic activity of RNA 
Ribonucleic acid (RNA) is an incredibly versatile molecule.  While it has been 
historically characterized as a vital component of the central dogma of biology as a messenger 
between the encoded information in DNA and a corresponding sequence of amino acids which 
form a protein chain, it also forms the core components of the modern translation machinery and 
is involved in gene regulation. 
 Notably, RNA has also been found to catalyze chemical reactions, a function that was 
previously attributed to proteins only.  In 1982, Kruger et al. found that an RNA intron from the 
organism Tetrahymena thermophila was able to splice itself – that is, to excise itself from the 
surrounding RNA sequence – without requiring any protein intervention.  In addition, Guerrier-
Takada et al. (1983) showed that the activity of the tRNA-processing enzyme RNase P was 
dependent on the RNA, not the protein, component of the enzyme.  These discoveries paved the 
way for future attempts to find "ribozymes," or RNA enzymes, both in vivo and in vitro. 
The RNA world hypothesis 
 The discovery of ribozymes implied that RNA may have played an important role in the 
origin of life on Earth.  An early biological system should be as simple as possible, requiring few 
classes of molecules which are capable of diverse functions.  Importantly, primitive forms of life 
2 
should be replicable, capable of evolution, and catalytic.  Among modern biologic 
macromolecules, RNA is the only one which satisfies all these criteria.  Assuming that extant 
biology retains at least some relics of early biology (which can be seen firsthand in the 
biochemical commonalities between all living organisms), the RNA world hypothesis (Gilbert 
1986) provides the most straightforward explanation for how life as we know it could have 
originated.  The hypothesis posits that during the early evolution of life, RNA was the sole 
biologic macromolecule; early life-like systems were based on RNA, which preceded DNA and 
proteins. 
 Early protein synthesis must have been catalyzed by RNA (or RNA-like) enzymes.  
Proteins as we know them could not have been present at the time of the first protein (peptide) 
synthesis.  While spontaneous polymerization of amino acids can occur, particularly in the 
presence of certain minerals (Lambert 2008), amino acids do not contain inherent information for 
self-replication of a particular peptide sequence.  Severin et al. (1997) found that a 33-residue 
synthetic peptide could catalyze the ligation of two short peptide sequences with some sequence 
specificity due to hydrophobic interactions and charge complementarity.  However, these 
reactions are not as specific as base pairing, and due to the inherent complexity and sequence 
specificity of the template peptide, it seems unlikely that this system could self-assemble and 
replicate with the fidelity necessary for Darwinian evolution to occur.  Peptides formed in the 
absence of replicable catalysts would not reach the level of complexity found in extant proteins.   
The roles of RNA and proteins in extant protein synthesis 
Modern protein synthesis, or translation, is highly complex and efficient, and itself 
dependent on proteins.  Firstly, protein enzymes known as aminoacyl-tRNA synthetases (AARS) 
catalyze two critical reactions: the activation of amino acids (by virtue of attachment to an AMP 
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molecule through a reactive phosphoric anhydride linkage), followed by the transfer of that 
amino acid through ester linkage to the 2′- or 3′-hydroxyl group of a corresponding tRNA (Fig. I-
1).   
Aminoacyl-tRNA synthetases are divided into two classes based on their amino acid 
sequence and mechanism of action.  For the most part, Class I synthetases  share a common 
structural domain (the Rossmann fold) and activate amino acids through the 2′-hydroxyl group of 
tRNA.  Class II synthetases generally share three structural motifs known as motifs 1, 2 and 3, 
and utilize the 3′-hydroxyl of ribose (Eriani et al. 1990).  One exception to this rule is the 
phenylalanyl-tRNA synthetase, which is a Class II AARS, but acylates the 2′-OH.   
Aminoacyl-tRNA synthetases depend on interactions with their cognate amino acids, 
ATP, and particular sequences and structures within their associated tRNAs (such as the 
anticodon loop) to carry out accurate and efficient acylation of tRNA (Saks et al. 1994).  
However, the natures of these interactions are quite variable between the synthetases; they do not 
all interact with the same sites of their cognate tRNAs.  The question of how the synthetases 
evolved, and whether they could have come from a simpler, RNA-based system, remains a 
subject of much debate and research. 
Once tRNA is acylated, proteins known as initiation and elongation factors recruit these 
"charged" tRNAs to the ribosome, where the tRNA anticodon bases are aligned with the codons 
of messenger RNA, allowing for peptide bond formation between adjacent amino acids.  
Charged tRNAs first associate with sites on the ribosome known as the peptidyl (P) and 
aminoacyl (A) sites, where peptidyl transfer occurs: the A site amino acid's amino group attacks 
the activated carboxyl group of the P site amino acid (or peptide), forming a peptide bond (Fig. I-
2).  Since the ribosome is comprised of both RNA and proteins, it was previously thought that   
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Fig. I-1.  Mechanism of tRNA aminoacylation.  The 3′- (shown here) or 2′-hydroxyl group of 
tRNA attacks the carbonyl carbon of the amino acid, in the acyl adenylate form.   
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Fig. I-2.  Generalized mechanism of peptide bond formation.  The amino group of the amino 
acid in the ribosomal A site attacks the carboxyl group of the amino acid esterified to the tRNA 
in the P site. 
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peptide bond formation in protein synthesis (peptidyl transferase) was directly dependent on the 
activity of ribosomal proteins. 
However, it also seemed possible that ribosomal RNA might play some role in peptidyl 
transferase.  Noller and Chaires (1972) first tested this by treating 30S ribosomal subunits with 
kethoxal, a chemical which modifies guanine residues.  This treatment inhibited peptide 
synthesis, presumable due to disruption of tRNA binding with the 16S (small subunit) ribosomal 
RNA. 
Further, when ribosomes from Escherichia coli were treated with proteinase K and SDS, 
which should eliminate ribosomal proteins, 20-40% of peptidyl transferase activity was retained 
(Noller et al. 1992).  Similar treatment of ribosomes from the thermophile Thermus aquaticus 
yielded activity 80% that of intact ribosomes.  Conversely, treatment of ribosomes with 
ribonuclease T1, which hydrolyzes RNA,  abolished peptidyl transfer.  These data indicated that 
the protein components of the ribosome may function to stabilize the RNA structure, but that 
they are not required for peptidyl transfer.  However, the treatments used in this study did not 
eliminate all ribosomal proteins, as this would require harsher conditions which would also 
disrupt the RNA.  Therefore, further evidence was needed to determine RNA's role, if any, in 
peptide bond formation. 
This evidence came in the form of the crystal structure of the Haloarcula marismortui 
large ribosomal subunit (Ban et al. 2000).  This work showed that there are no ribosomal 
proteins within 18 Å of the peptidyl transferase center; therefore, peptide bond formation must 
be mediated by ribosomal RNA (Nissen et al. 2000).  A proposed mechanism implicated one of 
the highly conserved nucleotides in the active site, A2451, as a general acid-base catalyst to 
facilitate peptide bond formation.  The N3 nitrogen of the adenine may have come close enough 
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to the α-amino group of the A-site tRNA to act in the reverse of the well-known chymotrypsin 
protease reaction.  Further work, however, showed that mutation of A2451 to C, G, or U did not 
abolish activity, indicating that the reverse-chymotrypsin mechanism may not be correct 
(Erlacher et al. 2005). 
Further work showed that A2451 of the 23S rRNA has a role in peptidyl transfer, but that 
this may be attributed to the 2′-OH of the ribose moiety, rather than the adenine (Lang et al. 
2008).  When the 2′-OH group was changed to another group without hydrogen donor capacity, 
such as –H, –OCH3, or –F, peptidyl transferase activity decreased dramatically.  Replacement by  
–NH2, which can function as a hydrogen donor, allowed the ribosome to function normally.  
These data, along with the acquired crystallographic structures, led the authors to conclude that 
the 2′-OH of A2451 forms a hydrogen bond with the 2′-OH of the P site tRNA A76.  This serves 
two purposes: it acts to stabilize the sugar conformation of the P site tRNA A76 ribose, and also 
hinders spontaneous 3′Æ 2′ migration of the P site amino acid, holding it in place for attack by 
the A site amino acid. 
In addition, a functional group on the P site tRNA itself is essential for peptidyl transfer.  
When the 2′-OH of A76 of the P site tRNA is changed to –H or –F, the rate of peptide bond 
formation decreases 106-fold (Weinger et al. 2004).  As this hydroxyl group is part of the 
substrate itself, these authors proposed that at least part of peptidyl transferase is mediated by 
"substrate-assisted catalysis."  A recently proposed model for peptidyl transferase involves the 
previously described role of the 2′-OH of 23S rRNA A2451, in addition to a proton shuttling 
system mediated by the 2′-OH of the P site tRNA A76 (Lang et al. 2008) (Fig. I-3).  The role of 
the ribosome in the actual mechanism of peptide bond formation, then, appears to be minor, and 
only involves a single 2′-OH group of rRNA. 
8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. I-3.  Proposed peptidyl transferase mechanism.  The tetrahedral intermediate of the 
peptide bond is stabilized by interaction with the 2′-OH of A2451 of the ribosome.  Once the 
tetrahedral intermediate is formed, the indicated proton shuttle mechanism can occur, resulting in 
a peptide bond.  Adapted from (Lang et al. 2008). 
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Therefore, it seems that the ribosome's major role is to position appropriate amino acids adjacent 
to each other, so peptide bond formation can occur.  This idea is supported by work from Sievers 
et al. (2004), which states that the ribosome is an "entropy trap;" it functions to lower the entropy 
of activation for peptidyl transfer, rather than the enthalpy of activation, which occurs in many 
enzymes such as general acid-base catalysts.   
While the ribosome interacts with many components to generate a specific amino acid 
sequence, it also has to be nonspecific enough to allow for any two amino acids to react in its 
active site.  Since it has been demonstrated that RNA can catalyze chemical reactions, and the 
translation machinery certainly did not emerge spontaneously in its current state, it is only 
logical to look for a simple, RNA-based system of peptide synthesis, which shares some, though 
not all, of the characteristics of the ribosome; it may have the ability to synthesize peptide bonds 
between specific amino acids. 
In vitro selection for RNA binding 
 RNA's inherent ability to store information as well as facilitate reactions allows for a 
unique way to study its function experimentally.  Systematic Evolution of Ligands by 
Exponential Enrichment, or SELEX, allows the user to isolate RNA molecules which perform a 
certain function from a starting pool of RNAs with random sequences (Joyce 1989, Tuerk and 
Gold 1990, Ellington and Szostak 1990).  RNAs that meet the selection criterion are isolated, 
reverse transcribed into DNA, amplified through the polymerase chain reaction, and then 
transcribed back into RNA.  This cycle of selection and amplification is repeated until a 
significant fraction of the RNA is shown to carry out the desired function.  This RNA can then 
be sequenced and further analyzed. 
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 The first successful SELEX experiments isolated RNA that bound to particular ligands 
(Tuerk and Gold 1990, Ellington and Szostak 1990).  In principle, one should be able to isolate 
an RNA "aptamer" that binds to almost any small molecule.  Aptamers have been found for 
biologically relevant molecules such as ATP (Sassanfar and Szostak 1993), as well as a variety 
of other small molecules and proteins. Aptamers can be highly specific for their ligands, and can 
also bind them with a very high affinity (Brody et al. 1999).   
Amino acid aptamers and the genetic code  
One of the major puzzles regarding the emergence of the modern translation system 
involves the nature of the genetic code.  The sequence of amino acids in a protein chain is 
dictated by the sequence of mRNA in the relevant gene, and also by the correct association of an 
amino acid with its cognate tRNA.  The mRNA sequence is read in triplets known as codons; a 
codon base pairs directly with the anticodon of a corresponding charged tRNA, and peptide 
bonds are then formed between adjacent amino acids (Fig. I-4).  Each amino acid is encoded by 
1-6 possible triplet codons; for example, phenylalanine is encoded by UUU or UUC.   
Where did this inherent association between amino acids and particular triplet sequences 
come from?  One hypothesis is that these associations are remnants of direct interactions 
between amino acids and RNA.  This idea seemed all the more plausible once it was discovered 
that the Tetrahymena self-splicing RNA (Kruger et al. 1982) is inhibited specifically by L-
arginine, and that this inhibition is due to binding between the RNA and the amino acid (Yarus 
1988). 
Since then, aptamers have also been found against a number of the other amino acids 
(Yarus et al. 2009), which allows us to address some of the questions about RNA-amino acid 
interactions in the RNA world.  Yarus et al. (2005) found that there is a statistically significant  
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Fig. I-4.  Amino acid sequence in a protein chain  is dictated by codons.  Triplet nucleotides 
in the messenger RNA (mRNA) sequence associate with corresponding anticodons on tRNA.  
Here, adjacent codons are for histidine and phenylalanine, leading to peptide bond formation 
between the two amino acids. 
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number of respective codons and/or anticodons within the sequences of 7/8 tested amino acid 
RNA aptamers.  This indicates that the observed associations between particular triplets and 
amino acids that we observe today may have "escaped" from direct stereochemical interactions 
between the two moieties in the past.   
This idea is further developed in the Direct RNA Template (DRT) hypothesis, which 
proposes that binding of multiple amino acids along an RNA aptamer template could have led to 
peptide bond formation, representing a rudimentary, coded peptide synthesis machine (Yarus 
1998, Yarus et al. 2009).   
The first step in the DRT model requires binding of individual, carboxyl-activated amino 
acids on an RNA template, in a manner analogous to that of the previously mentioned amino 
acid aptamers (Fig. I-5A).  The template may contain sequences which resemble codons, 
anticodons, or both.  Peptide bond formation may occur at this stage, provided that an RNA 
exists which binds two amino acids in close enough proximity, and in the correct orientation, for 
this to occur.  While the modern translation system requires at least three types of RNA as well 
as protein cofactors, early peptide synthesis could have been based on relatively simple, direct 
interactions between small RNAs and amino acids. 
 The second step in the DRT model involves the extension of the activating group (which 
was likely an esterified nucleotide) to resemble something like a modern tRNA (Fig. I-5B).  This 
tRNA could then insert itself between the amino acid and the template RNA (hemiDRT), 
provided it had the correct complementary codon/anticodon sequence. 
Finally, the last step requires the evolution of the hemiDRT template into the 
"riboribosome," which contains the peptidyl transfer functionality, while the coding component 
becomes a separate entity (proto-messenger RNA) (Fig. I-5C).  This model incorporates what we  
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Fig. I-5.  Direct RNA template model for the origin of translation.    A: Carboxyl-activated 
amino acids align on an RNA template, where peptide bond formation can occur.  B: Activating 
groups evolve into proto-tRNA; hemiDRT = partially direct RNA template.  C: Codons become 
a separate entity from the template, and the template becomes the primitive ribosome, or 
riboribosome.  Antic = anticodon.  Reproduced with permission from (Yarus et al. 2009). 
14 
now know about amino acid-RNA interactions and the genetic code, and provides a plausible 
mechanism for how an RNA-based peptide synthesis system could have evolved toward modern 
translation. 
In vitro selection for RNA catalysts 
 To further elucidate the capabilities of RNA, workers have used SELEX to find RNAs 
not only that bind ligands, but also that catalyze chemical reactions.  RNAs that facilitate the 
formation of bonds between two substrates, for example, can be selected by virtue of their 
covalent attachment to one of the substrates, followed by a selection step targeting the second  
substrate.  In addition, RNAs that catalyze self-splicing, self-ligation, or covalent attachment to a 
small molecule can be selected using gel mobility-shift assays or other chromatographic 
methods. 
 In the context of the RNA world, several workers have used SELEX to search for RNAs 
that catalyze ligation of RNA fragments.  Such an RNA might then be converted to a RNA 
synthesis machine, a necessary requirement for the RNA world hypothesis.  In fact, a number of 
RNA ligase ribozymes have been found (Robertson and Ellington 1999, Rogers and Joyce 2001, 
Jaeger et al. 1999), as well as several RNA polymerase ribozymes, one of which is able to extend 
a primer by at least 20 nucleotides, using the same activated nucleotides that biology uses today 
(Zaher and Unrau 2007). 
 In vitro selections have also found RNAs which catalyze two out of three of the major 
chemical steps required in modern protein synthesis.  Kumar and Yarus (2001) found a ribozyme 
which activates amino acids by virtue of their attachment to the 5′-terminal G of the ribozyme.  
This reaction is directly analogous to the synthesis of aminoacyl-AMP (catalyzed by aminoacyl-
tRNA synthetases) in modern protein translation.  Conversion of the amino acid to this reactive 
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acyl adenylate form is necessary before the next step in translation can occur, attachment of the 
amino acid to the 2′- or 3′-hydroxyl group of RNA.   
 This step, the charging of an amino acid by attaching it through ester linkage to RNA, can 
also be catalyzed by in vitro-selected RNA enzymes.  A family of 95-mer ribozymes were first 
isolated, which were able to attach the amino acid Phe (from the activated form PheAMP) to the 
ribozyme's own terminal 2′- or 3′-hydroxyl group (Illangasekare et al. 1995).  A variant of this 
ribozyme still functioned even after it was minimized to only 29 nucleotides (Illangasekare and 
Yarus 1999).  Interestingly, peptide bonds were also formed in this reaction; once the ribozyme 
was minimized, the product RNA-Phe-Phe formed, with the phenylalanines linked in peptide 
bonds.  While this was an interesting and unexpected result, it is important to note that this 
peptide bond formation does not parallel modern peptidyl transfer.  The peptides formed are very 
short, they are not based on a genetic code, and they are formed from highly reactive acyl 
adenylates, rather than the amino acid esters used in modern protein synthesis. 
 Another family of self-acylating ribozymes was also selected, using a very different 
selection protocol (Chumachenko et al. 2009).  In this case, the 3′ end of the RNA was free to 
vary its sequence, whereas before it was assigned as a primer sequence.  This family of 
ribozymes is exemplified by ribozyme C3, which uses PheAMP to acylate the 2′-OH of its 3′-
terminal uridine.  Molecular dynamics simulations as well as mutational analyses suggested that 
C3 has an unusually small active site, consisting only of three nucleotides. 
 
Purpose of the study 
Remaining issues for the RNA world hypothesis 
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 While a lot of pioneering work has been done that supports the RNA world hypothesis, 
some issues still remain.  Firstly, attempts to find a small RNA which catalyzes peptide bond 
formation from amino acid esters have not been successful.  Initial studies involved a selection 
for RNA which would bind to a transition state analogue for peptidyl transfer, CCdApPuro 
(Welch et al. 1997).  The rationale for this was that an ideal enzyme will stabilize the transition 
state of a reaction, and therefore a molecule which binds the transition state (or something very 
close to it) will accelerate a given reaction.  The RNAs that emerged from the selection did bind 
CCdApPuro, and interestingly, shared some sequence with the rRNA of the peptidyl transferase 
center of the ribosome.  The RNA did not, however, catalyze peptide bond formation (Welch 
1996). 
 Other attempts to find a small peptidyl transferase ribozyme have relied on covalent 
attachment of the selected RNA to the final product.  Jenne and Famulok (1998) started their 
selection with RNAs covalently bound to one amino acid, and isolated those which became 
attached to a second amino acid, presumably through a peptide bond.  Upon further 
investigation, however, they found that the second amino acid was attached to the RNA via ester 
linkage to an internal 2′-OH group, not through a peptide bond to the first amino acid. 
 Similarly, Zhang and Cech (1997) designed a selection to isolate aminoacyl-RNAs which 
would become bound to a second amino acid.  Their experiment was somewhat successful in that 
a peptide bond was formed between the two amino acids.  However, the second amino acid that 
participated in the reaction was found to be an aminoacyl adenylate contaminant from the 
synthesis of the aminoacyl ester (Gottlieb 2003).  Since aminoacyl adenylates are highly reactive 
and are not the substrates which biology uses in extant protein synthesis, this study does not 
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provide us with an evolutionary model for peptidyl transfer.  Thus, a small RNA which catalyzes 
even rudimentary coded peptide synthesis from aminoacyl esters has remained elusive. 
 Some have even suggested that a small ribozyme catalyzing peptidyl transfer cannot exist 
due to stereochemical limitations.  Koonin and Wolf (2007) have pointed out that amino acids 
binding to adjacent codons on an RNA sequence will not approach each other closely enough to 
form a peptide bond.  They propose that adaptor RNA molecules resembling tRNAs had to be 
present even from the beginning of the formation of the genetic code.  This idea, however, does 
not consider the possibility of overlapping codons, or the three-dimensional nature of RNA 
aptamers. 
 Other aspects of the RNA world hypothesis also have not yet been supported by 
experimental evidence.  The first step of the DRT model proposed by Yarus (1998) requires 
ester-activated amino acids aligned on a coded RNA template.  A simple method of activating 
amino acids in this manner has not been described previously, nor have RNA aptamers been 
found for short peptide sequences. 
 In addition, many of the ribozymes which have been found are not true enzymes.  The 
aforementioned self-acylating ribozymes, for example, are themselves modified once the 
reaction has taken place (they become attached to an amino acid).  A true enzyme is capable of 
modifying a substrate multiple times, remaining itself unaltered.  One ribozyme which can react 
with multiple substrates requires less information and material than a collection of single-
turnover ribozymes, and would provide better support for the RNA world hypothesis. 
 Finally, a great amount of information is required for the synthesis of many of the 
previously described ribozymes.  Even the small self-acylating ribozymes are of a length barely 
attainable (>20 nt) by the known RNA polymerase ribozymes.  The polymerase ribozymes 
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themselves are over 100 nucleotides long (Johnston et al. 2001, Zaher and Unrau 2007).  The 
amount of information and biomass, then, required to make a productive RNA world system may 
be of a level unobtainable by RNA-based RNA polymerization or abiotic syntheses of RNA, for 
example by polymerization on clay surfaces.  While relatively long RNA polymers (~50 nt) have 
been synthesized by adsorption of activated monomers to montmorillonite clay, there is no 
coding basis in this mechanism, and the synthesis of RNAs with particular sequences becomes 
increasingly difficult as RNA length increases (Joshi et al. 2009). 
 
Summary 
Small RNA-amino acid interactions and the origin of translation 
 In this work, I will show that each of these issues has been addressed by two unique yet 
related projects, thus adding additional support to the RNA world hypothesis.  Firstly, I show 
that RNA-catalyzed RNA aminoacylation can occur in trans; that is, I report the first true 
aminoacylating RNA enzyme which reacts with biologically relevant substrates.  This ribozyme 
is based on modification of the previously described C3 ribozyme (Chumachenko et al. 2009).  I 
show that this ribozyme is much smaller than almost all other ribozymes, and that it requires 
only simple substrates and environmental factors, thus making its existence in an RNA world 
quite plausible.  
 This tiny ribozyme makes a variety of RNA-aminoacyl and RNA-peptidyl products, 
adding even more complexity to the repertoire of possible products in a simple RNA world.  The 
identities and kinetics of formation of the various products are reported.   
Finally, I will show that a scaffold for RNA-based peptide bond formation has been 
found, in the form of RNA sequences that bind the dipeptide His-Phe.  This adds support to the 
19 
Direct RNA Template hypothesis, and suggests that direct RNA-amino acid interactions could 
have been the basis for the modern-day genetic code. 
This work not only offers insight into the origin and evolution of protein synthesis, but 
also causes us to reevaluate the potential of RNA catalysis and our current methods of enzyme 
selection. 
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CHAPTER II  
RNA AMINOACYLATION BY A FIVE-NUCLEOTIDE RIBOZYME 
 
Introduction 
The RNA world hypothesis requires each of the chemical steps required for protein 
synthesis to be catalyzed by RNA enzymes, without protein intervention.  The step investigated 
here is the attachment of an amino acid to the 2′- or 3′-hydroxyl group of an RNA molecule.  In 
modern protein synthesis, this step is catalyzed by aminoacyl tRNA synthetase enzymes, and is 
followed by association of the acylated RNA with the translation machinery and subsequent 
peptide bond formation.  Thus, RNA acylation serves as a mechanism to activate amino acids for 
coded protein synthesis. 
Several families of self-acylating ribozymes have been isolated using SELEX (Joyce 
1989, Ellington and Szostak 1990, Tuerk and Gold 1990).  For example, the C3 ribozyme reacts 
with PheAMP to acylate its own 3′-terminal nucleotide (Chumachenko et al. 2009).  C3 is the 
result of a novel selection designed to allow for free sequence variation of the 3′ end of the RNA.  
C3 represents the combined common structural elements of many ribozymes which emerged 
from the selection; its predicted 2-dimensional structure is shown in (Fig. II-1). 
While most of the structure of C3 was consistent among the isolated RNAs, there was 
surprisingly little sequence similarity (Chumachenko et al. 2009).  In fact, there were only three 
highly conserved nucleotides: the 3′-terminal U, and a 5′-GU-3′ sequence apposed to the U (Fig. 
II-1).  This suggested an unusually small active center for the ribozyme.  This hypothesis was 
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supported by mutational analyses (changing the identity of the nucleotides in the left- and right-
hand helices did not abolish activity) as well as molecular dynamics simulations (only the three 
aforementioned nucleotides were involved in the predicted reaction mechanism).  
 
 
 
 
 
 
 
Fig. II-1.  Two-dimensional structure of C3 ribozyme.  Predicted active site nucleotides are in 
black.  Ester bond forms between Phe and the 2′-OH of the indicated uridine. 
 
 
The initial aim of the following work was to test this hypothesis by constructing and 
testing a minimized version of C3.  If only three nucleotides are required for this acylation 
reaction, then most of the surrounding structure of C3 should be expendable.  Small ribozymes 
would be much more likely to exist in the RNA world than large, complex ribozymes. 
 In addition, the C3 ribozyme is not a true enzyme because it is modified by its own 
reaction, and thus cannot execute turnover.  Thus, another aim was to determine whether or not 
the ribozyme could work in trans. 
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 Here I show that not only can a variant of the C3 ribozyme function in trans, but it can 
also be minimized to a tiny, five-nucleotide long ribozyme (one of the smallest ribozymes ever 
reported), which reacts with PheAMP and a partially complementary four-nucleotide RNA 
substrate.  In addition, a multitude of products are formed from the initial acylated RNA product, 
which are RNA-peptides.  These data indicate that biologically relevant functions could have 
arisen more easily during the RNA world than was thought previously. 
 
Results 
 
Minimization of C3 ribozyme 
 The C3 ribozyme was first modified by being separated into two parts: an "enzyme" 
strand and a "substrate" strand.  The left-hand helix, the site of association between the enzyme 
and substrate, was also extended to confer stability to the complex (Fig. II-2, Structure B).  When 
the enzyme and 32P-labeled substrate were reacted with PheAMP, acylated RNA product was 
observed, as measured by acrylamide gel electrophoresis (modified RNA has a slower gel 
mobility than unreacted RNA).   
Further modified ribozyme/substrate complexes also yielded acylation activity.  A 
ribozyme which completely lacked the entire right-hand helix of C3 still functioned, despite the 
loss of conserved secondary structure from the original ribozyme family (Fig. II-2, Structure C).  
Finally, I was able to shorten the enzyme/substrate helix, and to eliminate a highly conserved U 
from the 5′-end of the ribozyme, without abolishing activity (Fig. II-2, Structures D-H).  The 
final result of this variation and minimization is a 5-nt ribozyme, 5′-GUGGC-3′, and a 4-nt RNA 
substrate, 5′-GCCU-3′ (Fig. II-2, Structure H). 
The 5-nt enzyme/4-nt substrate complex appears to be the smallest active acylation 
complex under our conditions.  Shortening the enzyme/substrate helix from three base pairs to  
23 
 
 
 
 
Fig. II-2.  Structures and assays of C3 ribozyme variants.  A: C3 ribozyme.  B-G: 
intermediate trans variants.  H: final 5-nt ribozyme/4-nt substrate complex.  Reaction conditions: 
100 µM enzyme RNA, 37 µM substrate RNA, 100 mM KCl, 5 mM MgCl2, 100 mM HEPES pH 
7.0, 2.6 mM PheAMP, 4o C, 10 min. 
24 
two base pairs resulted in a complex which did not effectively acylate the substrate (Fig. II-3).  
Therefore, it seems that three base pairs are necessary and sufficient to confer enough stability 
for substrate/product association and subsequent transacylation. 
Further, the 5′-G of the ribozyme appears indispensable for the reaction.  Both mutation 
of the 5′-G to C, and complete elimination of the 5′-terminal nucleotide, abolished product 
formation (Fig. II-4).  These data are consistent with observations from the C3  
ribozyme, and thus support the hypothesis that the two ribozymes are using identical or similar 
mechanisms. 
Determination of active site 
While it was clear that reaction of GUGGC and GCCU with PheAMP resulted in 
modification of GCCU, I needed to further determine the site of reaction on the RNA.  I 
predicted that the gel-shifted products were the result of the addition of one or more 
phenylalanines to the 2′-OH of the 3′-terminal U of substrate GCCU, as was the case for the 
analogous U of C3.  To test this, I reacted GUGGC and PheAMP with a substrate lacking the 3′-
terminal U, 5′-GCC-3′.  No gel-shifted products were evident from this reaction (Fig. II-5, Lane 
5).  In addition, treatment of GCCU with periodate (NaIO4), which selectively oxidizes the cis-
glycol of the terminal ribose of RNA, rendered the substrate unreactive (Fig. II-5, Lane 4).  Both 
these data indicate that the 3′-terminal U is the site of reaction of the RNA substrate. 
 To further elucidate the site of reaction, I constructed a modified version of GCCU which 
lacked the 3′-OH group of the terminal U, GCC3′dU.  This substrate did appear to be reactive, 
which indicates that the 3′-OH is not required for the reaction (Fig. II-5, Lane 3).  A 
complementary substrate lacking the terminal 2′-OH group, however, was unreactive (Fig. II-5, 
Lane 2).  Therefore, the 2′-OH is likely the site of reaction, as was the case for C3. 
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Fig. II-3.  Three base pairs are required between ribozyme and substrate.  Reaction 
conditions: 4o C, 60 min, 12 µM ribozyme (when present), 24 µM RNA substrate, 100 mM 
PIPES pH 6.4, 100 mM NaCl, 100 mM KCl, 5 mM CaCl2, 5 mM MgCl2, 0.1 mM MnCl2, 3.5 
mM PheAMP (when present). 
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Fig. II-4.  5′-G of GUGGC is required for reaction.  Reaction conditions: 25 µM enzyme 
RNA, 50 µM GCCU, 100 mM KCl, 5 mM MgCl2, 100 mM HEPES pH 7.0, 2.6 mM PheAMP, 
4o C, 30 min. 
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Fig. II-5.  Initial acylation reaction occurs only at 2′-OH.  Lane 1 substrate = GCCU, 2 = 
GCC2′dU, 3 = GCC3′dU, 4 = GCCU + NaIO4, 5 =GCC, 6 = dGdCdCrU, 7 = GCCU + PheAMP, 
no GUGGC, 8 = GCCU + GUGGC, no PheAMP.  Reaction conditions: 10 µM ribozyme 
GUGGC, 20 µM RNA substrate, 100 mM KCl, 5 mM MgCl2, 100 mM HEPES pH 7.0, 2.0 mM 
PheAMP; incubation at 4o C for 30 min.   
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Further, to show that the reaction could not be occurring at an internal hydroxyl group, I 
used a DNA/RNA hybrid substrate which lacks internal free –OH groups, dGdCdCrU.  This 
substrate was active, further supporting the hypothesis that the terminal U is the site of reaction 
(Fig. II-5, Lane 6).  It is also interesting to note that the reaction still occurred in a DNA/RNA 
hybrid complex; this may have implications for similar reactions occurring on molecules with 
heterogeneous backbones. 
 Finally, I showed that the apparent formation of three acylated products is dependent on 
the presence of all three factors: GUGGC, GCCU, and PheAMP.  Control reactions lacking 
ribozyme GUGGC (Fig. II-5, Lane 7) and PheAMP (Fig. II-5, Lane 8) did not result in the 
formation of product.  Therefore, our final conclusion is that product formation is the result of 
the reaction between PheAMP and the 2′-OH of substrate GCCU, mediated by GUGGC, as 
shown in (Fig. II-6). 
Chemical requirements 
 To further test the chemical requirements for this reaction, I carried out the reaction in the 
presence and absence of different cations.  The reaction (as measured after 60 min at 4o C) yields 
the most product in the presence of Mg2+ and K+ (Fig. II-7).  The removal of divalent cations 
(Mg2+), however, only reduces activity by 6.5%.  This is unusual, since most ribozymes require 
divalent cations for proper folding.  The GUGGC/GCCU complex has a simple structure due to 
its small size, and thus it is not surprising that it is able to function in the absence of divalents. 
 Residual activity of GUGGC/GCCU was even detected in the near absence of all cations 
(Fig. II-7).  The complete removal of cations was not possible, however, due to the necessary 
addition of NaOH to the reaction buffer.  However, it is impressive that the ribozyme functions 
quite well in the presence of either K+, Mg2+, or Na+ alone.  Such minimal chemical requirements 
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support the hypothesis that ribozymes could have functioned in a variety of different chemical 
conditions during early evolution. 
GUGGC exhibits a pH dependence profile that is consistent with its proposed mechanism 
of action.  Product formation is slower at acidic pH, and increases as pH becomes more basic 
(Fig. II-8).  This is for two reasons: PheAMP stability should decrease with increasing pH, and 
the carbonyl carbon of PheAMP is more susceptible to nucleophilic attack by the 2′-OH of 
GCCU at basic pH.  At pH 7.0, the reaction proceeds efficiently while minimizing spontaneous 
PheAMP degradation, and so that pH was used for all further experiments.  The ability of the 
ribozyme to function at a range of pH values argues for its likely survival in an RNA world. 
 The small ribozyme/substrate complex is also able to react with aminoacyl substrates 
other than PheAMP.  Reaction of the RNA with both MetAMP and PheUMP yielded product  
(Fig. II-9).  This is consistent with the data obtained for the C3 ribozyme, as well as the 
mechanistic model proposed in (Chumachenko et al. 2009).  The model predicts that neither the 
adenosine moiety of PheAMP, nor the side chain of the amino acid, are participating directly in 
the reaction.  GUGGC/GCCU may be able to utilize many different substrates, in addition to 
those tested here. 
Product identification 
The next step was to determine the identity of the different products.  At least three 
products were evident from the reaction between GUGGC/GCCU and PheAMP, as monitored by 
gel electrophoresis (Fig. II-5, Lane 1).  Given that a previously isolated ribozyme also hosted the 
formation of RNA-Phe-Phe, it seemed possible that these three products may be the result of 
peptide bond formation (Illangasekare and Yarus 1999). 
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Fig. II-6.  Schematic of GUGGC/GCCU reaction.  Ribozyme GUGGC reacts with PheAMP 
and RNA substrate GCCU to form a bond between phenylalanine and the 2′-OH of the substrate 
RNA. 
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Fig. II-7.  Aminoacylation reaction does not require divalent cations.  All reactions contained 
10 µM GUGGC, 20 µM GCCU, 1.9 mM PheAMP, 100 mM HEPES pH 6.5, 10 mM NaOH.  
100 mM KCl, 5 mM MgCl2, or 100 mM NaCl were used where indicated.  Incubation at 4o C, 60 
min. 
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Fig. II-8.  pH dependence of GCCU acylation.  Conditions: 4o C, 12 µM GUGGC, 24 µM 
GCCU, 100 mM KCl, 5 mM MgCl2, 0.1 M buffer.  Buffer = MES for pH 5.5, 6.0, 6.5; HEPES 
for pH 7.0, 7.5. 
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Fig. II-9.  GUGGC/GCCU reacts with varying aminoacyl substrates.  Reaction conditions: 
20 µM GUGGC, 10 µM GCCU, 100 mM KCl, 5 mM MgCl2, 100 mM HEPES pH 7.0, 4o C, 30 
min; 11.8 mM PheAMP, 14.5 mM MetAMP, or 12.6 mM PheUMP where indicated. 
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To test this, I treated a completed reaction with leucine aminopeptidase (LAP), a protein 
enzyme that hydrolyzes peptide bonds, but not ester bonds.  Over time, Products 2 and 3 are 
degraded by LAP, but Product 1 is not (Fig. II-10).  Therefore, Product 1 is likely GCCU-Phe 
ester, and Products 2 and 3 are GCCU-Phe2 and GCCU-Phe3 (with the phenylalanines linked in 
peptide bonds), respectively.  
Mass spectrometry independently confirmed the identities of Products 1 and 2.  Product 1 
was purified (along with GUGGC and GCCU) and subjected to MALDI mass spectrometry.  
Three peaks were evident in the mass spectrum: two with masses corresponding to the quadruply 
protonated forms of GUGGC and GCCU, and one corresponding to the quadruply protonated 
form of GCCU plus one phenylalanine (Fig. II-11A, Fig. II-12A-C).  Mass spectrometry of 
purified Product 2 resulted in a peak with the mass of GCCU plus two phenylalanines, consistent 
with our prediction of the structure of Product 2 (Fig. II-11B, Fig. II-12 D).   
 
Discussion 
 Here I have demonstrated that a very small ribozyme can aminoacylate an RNA substrate 
in trans, using the same activated form of amino acid that biology uses today.  While other 
transacylating ribozymes have been reported, they require their aminoacyl substrates to be 
activated as cyanomethyl, 3,5-dinitrobenzyl, or p-chlorobenzyl esters, which do not resemble the 
biological substrate, and thus do not provide a link between the RNA world and modern biology 
(Lee and Suga 2001, Murakami et al. 2002).  In addition, PheAMP is highly water soluble and 
easy to synthesize.  Thus, the GUGGC/GCCU system may be preferable for use in further 
biological applications. 
 Small ribozymes have also been reported; for example, a trinucleotide has been shown to 
cleave an RNA substrate in the presence of manganese (Kazakov and Altman 1992).  However,  
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Fig. II-10.  Higher products are RNA-peptides.  Aminoacylation reaction conditions: 10µM 
GUGGC, 20 µM GCCU, 100 mM KCl, 5 mM MgCl2, 100 mM HEPES pH 7.0, 1 mM PheAMP; 
incubation at 4o C for 30 min.  LAP = leucine aminopeptidase, 23 ng/µl. 
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Fig. II-11.  MALDI-TOF mass spectrometric analysis of RNA and Products 1 and 2.  A: 
Product 1 and RNA. B: Product 2.  Numbers in parentheses indicate theoretical mass of 
protonated products; outside parentheses, observed mass. 
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Fig. II-12.  Chemical structures of RNA and products. A: GUGGC, exact mass 1580.22.  B: 
GCCU, exact mass = 1274.13.  C: GCCU-Phe (Product 1), exact mass = 1421.20.  D: GCCU-
Phe2 (Product 2), exact mass = 1568.27. 
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GUGGC facilitates the joining of two moieties, rather than cleavage of one, which can be 
considered a more productive and challenging task for a ribozyme.  Also, GUGGC does not 
require the specific conditions necessary for the Mn2+-dependent ribozyme. 
 The existence of such a small ribozyme creates a strong argument for the RNA world 
hypothesis.  Small ribozymes are preferred in the RNA world because firstly, they do not require 
a lot of material to be assembled.  For comparison, the Thermus thermophilus phenylalanyl-
tRNA synthetase has a molecular weight of 284,000 g/mol, and GUGGC has a molecular weight 
of 1,580 g/mol.  While the protein enzyme catalyzes another reaction in addition to RNA 
acylation (aminoacyl activation), it is remarkable that the same reaction can be catalyzed by a 
ribozyme with 0.56% the amount of mass. 
 In addition, the fact that the ribozyme/substrate complex is only comprised of nine 
nucleotides makes its existence in the RNA world all the more likely.  The sizes of the ribozyme 
and substrate are well within the catalytic repertoire of the currently known RNA-RNA 
polymerases (Zaher and Unrau 2007), as well as clay-catalyzed RNA polymerization (Joshi et al. 
2009). The short length of the ribozyme makes it likely to be synthesized even under random 
conditions.  In addition, since the active site is only comprised of three nucleotides (the 
overhanging G and U of the ribozyme, and the 3′-terminal U of the substrate), the three base 
pairs between the ribozyme and substrate are free to vary without abolishing activity, as long as 
they base pair (Illangasekare and Yarus 2010, submitted).  Thus, very little information is 
required to generate a biologically active RNA complex. 
 Thus, small RNAs could have functioned as rudimentary aminoacyl-tRNA synthetases.  
The ribozyme characterized here, however, is not specific to a particular aminoacyl substrate, 
and has little sequence specificity.  It is clear, then, that amino acid recognition and the 
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emergence of the genetic code occurred later in the RNA world.  Nonspecific association 
between amino acids and RNAs could have served initially as a way to activate amino acids for 
peptide bond formation.  Esterified amino acids, while activated, are not as unstable as acyl 
adenylates (PheAMP).  Thus, it may have been beneficial during the RNA world to find an 
alternative way to activate amino acids for longer-term storage or stability once transferred to 
conditions which would hydrolyze adenylates. 
 Similarly, the peptide formation demonstrated here, while not coded, may have served as 
a primitive source of short peptides.  These peptides could have associated with and stabilized 
particular RNA molecules, which could have evolved to catalyze peptide bond formation 
between amino acids (see Chapters V and VI). 
 
Methods 
RNA and aminoacyl substrate synthesis 
 RNA was synthesized by Dharmacon (Lafayette, CO).  GUGGC = 5′-GUGGC-3′; GCCU 
= 5′P-GCCU-3′; 5′OH-GCCU = 5′-GCCU-3′; GCCU2′dU = 5′-GCC-2′-dU; GCC = 5′-GCC-3′; 
dGdCdCrU = 5′-dGdCdCU-3′.  
 RNA GCC3′dU was prepared by first synthesizing 5′-O-(4,4′-Dimethoxytrityl)3′-
deoxyuridine (3) as follows (Fig. II-13).  3′-deoxyuridine (1; MP Biomedicals; 991 mg,  
0.434 mmol) was dissolved in 5 ml anhydrous pyridine and pyridine was then removed under 
vacuum while stirring. Solid was then re-dissolved in 2 ml pyridine.  Dimethoxytrityl chloride 
(2; 170 mg, 0.499 mmol) was dissolved in 12 ml pyridine and slowly added to 3′-deoxyuridine 
solution.  Solution was stirred at room temperature for 4 hours.  All solutions were sequestered 
from exposure to air throughout. 
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Reaction was then quenched by addition of 5 ml methanol, and solvent was removed by 
rotary evaporation.  Remaining solvent evaporated overnight in a vacuum chamber.  Product was 
then dissolved in 1 ml acetonitrile and purified through a silica column (acetonitrile elution).  
Final product fractions (confirmed through TLC, 1:1 hexane:acetonitrile) were pooled and rotary 
evaporated.  Yield: 71%. 
 DMT-protected 3′dU (3) was then sent to Dharmacon for immobilization of 3′-dU on 
glass and synthesis of 5′-GCC-3′-dU. 
 PheAMP, PheUMP and MetAMP were synthesized by the method of (Berg 1958) with 
modifications and purification as described in (Chumachenko et al. 2009).  Yield: PheAMP 
85%; PheUMP 67%; MetAMP 36%. 
Aminoacylation assays 
   For aminoacylation assays, substrate RNA was 5′-labeled with 32P using T4 
polynucleotide kinase (New England BioLabs, Inc.).  Kinase conditions: 5 µM substrate RNA, 
1X T4 Polynucleotide Kinase Forward Reaction Buffer (Invitrogen), 0.625-1.25 µM (7.5 
mCi/ml) γ-32P-ATP, 0.5 units/µl T4 polynucleotide kinase; 37o C for 20-30 minutes.  Kinase 
reaction was then passed through a Micro Bio-Spin 6 chromatography column (Bio-Rad) to 
remove excess γ-32P-ATP or purified using polyacrylamide gel electrophoresis followed by 
ethanol precipitation.   
 Standard aminoacylation conditions were as follows: GUGGC 10 µM, GCCU 20 µM, 
32P-GCCU ≤0.3 µM, KCl 100 mM, MgCl2 5 mM, HEPES pH 7.0 100 mM, PheAMP 1-2 mM; 
incubation at 4oC for 30 min.  RNA, salts, and buffer were first incubated at 4o C for 10 min.  
PheAMP (1-10 µmol) was dissolved in cold water, filtered, and added to RNA solution.  After 
incubation, the reaction was stopped by addition of xylene cyanol/bromophenol blue dye 
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containing sodium acetate, and either frozen on dry ice or loaded directly into gel for 
electrophoresis.  Conditions for product isolation experiments for mass spectrometry used 25 µM 
GUGGC, 50 µM GCCU, and 2.5 mM PheAMP.   
 Periodate reaction contained 100 µM 5′OH-GCCU, ≤0.3 µM  32P-GCCU, 60 mM KCl, 5 
mM MgCl2, 30 mM NaOAc pH 5.2, 8.2 mM NaIO4 (total volume 100 µl).  Reaction was 
incubated on ice in the dark for 2 hours.  Then glucose was added to 14.9 mM to consume excess 
periodate and the reaction sat on ice for ~10 min.  Reaction was then passed through a Micro 
Bio-Spin 6 column (Bio-Rad) and lyophilized.  Product was re-dissolved in 15 µl water and 1 µl 
was mixed with GUGGC, KCl, MgCl2, HEPES, and PheAMP as in standard assay conditions.  
 Gel electrophoresis was performed using polyacrylamide gel from 12% acrylamide, 6 M 
urea, 0.1 M sodium acetate pH 5.2.  Gels were run from 6-16 hours at 4o C until bromophenol 
blue had migrated at least 15 cm.  Gels were dried, exposed to a phosphorimager screen and 
analyzed with a Bio-Rad Molecular Imager FX and QuantityOne® software (Bio-Rad). 
Purification and identification of Products 1 and 2 
 Removal of salts and buffer from products were necessary for MALDI mass 
spectrometric analysis.  Product 1, GUGGC, and GCCU were purified from a standard 
aminoacylation reaction using a Waters Sep-Pak® C18 cartridge.  Sep-Pak was equilibrated with 
1.8 ml methanol followed by 7 ml water.  Completed aminoacylation reaction (100 µl, aqueous) 
was added to Sep-Pak and washed with 3.5 ml water followed by 200 µl methanol.  600 µl 
methanol was then added, collected, and concentrated with a speed-vac.  Gel electrophoresis and 
analysis confirmed the presence of radiolabeled GCCU and Product 1 in collected fractions.  A 
parallel Sep-Pak purification with a scaled up (10x volume), cold reaction was performed for 
mass spectrometric analysis. 
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 A Waters Atlantis® 5 µm dC18 column was used to separate Product 2 from other 
reaction components through high performance liquid chromatography (HPLC).  Gradient: 95% 
A/5% C for 10 min, ramp to 70% A/30% C for 33 min.  Flow: 1 ml/min.  Solvent A = 0.1 M 
NH4OAc, pH 4.5; Solvent C = acetonitrile.  Fractions were collected (one/min) and counted 
using a scintillation counter to detect elution of products.  Product 2 (confirmed by gel 
electrophoresis) was present in fractions eluted between 32 and 34 min.  A parallel HPLC 
purification was done with a scaled up, cold reaction and fractions 32-34 for both hot and cold 
reactions were collected, lyophilized and resuspended in 100 µl water. 
 A second HPLC purification was necessary to remove ammonium acetate buffer from 
Product 2.  Gradient: 95% B/5% C for 20 min, ramp to 100% C for 10 min.  Solvent B = water.  
Counts were highest in fractions 7-13 for hot reaction; corresponding fractions were collected for 
scaled up cold reaction, pooled, and lyophilized. 
 Mass spectrometry 
Mass spectrometry was carried out using a Voyager-DE STR MALDI-TOF mass 
spectrometer (ABI).  Dried samples were dissolved in acetonitrile and co-spotted with α-cyano-
4-hydroxycinnamic acid matrix solution.  Analysis was performed in the negative, reflector 
mode and masses were calibrated using a three-peptide standard.  Spectra were averaged over 50 
laser shots. 
Peptidase reactions 
Leucine aminopeptidase (microsomal from porcine kidney) was purchased from Sigma-
Aldrich.  Peptidase reactions were carried out in the presence of 0.1 M HEPES pH 7.0. 
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CHAPTER III  
DIESTER FORMATION BY A FIVE-NUCLEOTIDE RIBOZYME 
 
Introduction 
 One of the interesting phenomena of acylated tRNAs is the dynamic nature of the ester 
bond between the tRNA and its cognate amino acid.  Transfer RNAs are either acylated at their 
2′-hydroxyl groups (in the case of Class I aminoacyl-tRNA synthetases and the Class II 
phenylalanyl-tRNA synthetases) or their 3′-hydroxyl groups (for the other Class II synthetases) 
(Eriani et al. 1990).  However, once an amino acid becomes attached to the tRNA, it migrates 
back and forth between the 2′- and 3′-hydroxyl groups, through a process known as 
transesterification, or transacylation (Griffin et al. 1966).   
Transacylation occurs relatively rapidly, at an equilibration rate k(2′↔3′) of 4-15 s-1 
under physiological conditions (Taiji et al. 1983).  Peptide bond formation occurs exclusively 
with the amino acid attached to the 3′-hydroxyl group of tRNA (Taiji et al. 1985), at a rate of 15-
20 bonds formed s-1.  Since the rate of transacylation is slower than the rate of peptide bond 
formation, there must be a mechanism in place in the modern translation system which stabilizes 
the 3′-isomer, holding the amino acid in place for peptidyl transfer. 
 While most aminoacyl-tRNA synthetases (AARS ) acylate a single hydroxyl group on 
their cognate tRNA, there is at least one example of an AARS which acylates both groups.  At 
high concentrations, the phenylalanyl-tRNA synthetase from Thermus thermophilus has been 
shown to attach two phenylalanine residues to tRNAPhe: one to the 2′-OH, and one to the 3′- 
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(Stepanov et al. 1992).  The product of this reaction is a RNA-Phe diester, bis(2′, 3′-O-
phenylalanyl)-tRNA (Fig. III-1). 
These doubly acylated tRNAs are fully functional in both Escherichia coli and rabbit 
reticulocyte lysate protein synthesis assays (Wang et al. 2006).  The 3′-esterified amino acid 
reacts first (Taiji et al. 1985), and the 2′-acylated tRNA exits the ribosome.  Transacylation then 
occurs, and the mono-acylated tRNA can re-enter the translation complex.  The remaining amino 
acid can then be incorporated into the growing peptide chain. 
 For an enzyme to acylate ribose at both hydroxyl groups, it must be able to either a) 
acylate at both the 2′ and 3′ positions, or b) react at its canonical site with an already acylated 
product, where the amino acid has migrated to the other hydroxyl group.  Both these models 
require a certain degree of flexibility, or nonspecificity, of the active site.  The GUGGC/GCCU 
system fits this description, as it reacts with a variety of substrates, and has a relatively 
unconstrained active site comprised of only three nucleotides (Chumachenko et al. 2009).  While 
it has been shown that GUGGC reacts exclusively with the 2′-hydroxyl group of GCCU (Chapter 
II), mechanism b) could still be in effect, if the right conditions are met.  Once the first product, 
GCCU-Phe, is formed, and transacylation occurs, the enzyme may be able to repeat acylation to 
form a doubly acylated RNA (an RNA-Phe diester). 
In Chapter II, I showed that the ribozyme GUGGC can react with a substrate RNA 
(GCCU) and PheAMP to generate at least three acylated RNA products.  In this chapter, I will 
show that even more products form when the reaction conditions are changed to increase the rate 
of product formation.  These products are RNA-Phe diesters, as well as peptide extensions of 
those products. 
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Fig. III-1.  Structure of bis(2′, 3′-O-phenylalanyl)-tRNA. 
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Results 
Multiple product formation 
 Previous experiments with GUGGC/GCCU and PheAMP used PheAMP concentrations 
of 1-2 mM and GCCU:GUGGC ratios of 2:1.  These experiments yielded up to three acylated 
products, which were identified as GCCU-Phe, GCCU-Phe2, and GCCU-Phe3, where the 
subscripts indicate the number of phenylalanines linked in peptide bonds.  Following these 
experiments, the conditions were changed in order to increase the rate of product formation, by 
increasing PheAMP concentration to ~10 mM, and changing the RNA substrate:enzyme ratio to 
1:2.  Under these conditions, at least five previously unseen, slower-migrating products formed, 
as measured by gel electrophoresis (Products 4-8, Fig. III-2). 
 One possibility was that these products were RNA-peptides GCCU-Phe5 through GCCU-
Phe8, the result of the addition of subsequent phenylalanines to Product 3.  However, if this were 
the case, one would expect to see the amount of product decrease as the apparent length of the 
poly-Phe chain increases.  This is not the case, however; for example, the apparent amount of 
Product 6 exceeds the amount of Product 4 at any given time point (Fig. III-2). 
 To test whether the higher products could be RNA-peptides, I treated a completed 
reaction with leucine aminopeptidase (LAP).  Interestingly, all products were degraded by the 
protease except for Products 1 and 5 (Fig. III-3).  This indicates that Product 5 is not simply 
GCCU-Phe5, but some other GCCU/Phe product.  Since Product 5 exhibits similar behavior to 
Product 1, a RNA-Phe ester, and since bis(2′, 3′-O-phenylalanyl)-tRNAs are known to be 
synthesized in nature (Stepanov et al. 1992), it seemed likely that Product 5 could be the diester 
bis(2′, 3′-O-phenylalanyl)-GCCU (here notated GCCU-(Phe/Phe)).  While this molecule has the  
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Fig. III-2.  GUGGC/GCCU reaction under modified conditions creates additional products.  
Products are numbered according to their gel mobility.  Reaction conditions: 10 µM GCCU, 20 
µM GUGGC, 11.8 mM PheAMP, 0.1 M HEPES pH 7.0, 100 mM KCl, 5 mM MgCl2, 4o C.  Gel 
by M. Illangasekare. 
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Fig. III-3.  Product 5 is resistant to protease degradation. Aminoacylation reaction 
conditions: 20 µM GCCU, 10 µM GUGGC, 100 mM KCl, 5 mM MgCl2, 100 mM HEPES pH 
7.0, 18.20 mM PheAMP; incubation at 4o C for 30 min.  LAP = leucine aminopeptidase, 8.9 
ng/µl. 
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same mass as Product 2, it has a more positive charge due to its additional amino group, which 
tends to be protonated under our gel buffer conditions (Fig. III-4).  Therefore, it should migrate 
more slowly than Product 2 in an acrylamide gel. 
Identification of diesters 
Mass spectrometric analysis of Product 5 confirmed its identity as GCCU plus two 
phenylalanines.  The MALDI mass spectrum of gel- and HPLC-purified Product 5 showed two 
peaks: one at m/z = 1425.43, the previously observed mass of quadruply protonated Product 1, 
and one at m/z = 1572.48 (Fig. III-5).  The presence of the first peak is due to Product 1 
contamination in the sample, either due to gel purification or hydrolysis during handling.  The 
second, more prominent peak has the same mass as quadruply protonated GCCU plus two 
phenylalanines (see Fig. III-4).  Further, there is no peak at m/z = 2013, the predicted mass of 
GCCU-Phe5.   
 To further demonstrate that Product 5 possesses two phenylalanine esters, I treated gel-
purified Product 5 with Sulfo-NHS-LC-biotin.  Biotin reacts with the primary amino groups of 
amino acids, and will therefore change the gel mobility of RNA-amino acid esters.  Product 5 
formed first one, and then another, biotinylated product (Bands B and C, Fig. III-6A).  
Conversely, Products 1 and 2 only formed one biotinylated product each (Fig. III-6B).  
Therefore, it is apparent that there are two free amino groups (and thus two phenylalanines, 
presumably attached to the RNA through their carboxyl groups) in Product 5, and only one free 
amino group in Products 1 and 2, as predicted. 
 Finally, Product 5 was subjected to mild base hydrolysis to determine if it is truly an 
ester.  Esters are relatively unstable, and will slowly hydrolyze under heat and mild base 
treatment.  Product 1, for example, hydrolyzes to GCCU when incubated at 37o C, pH 8.5 (Fig.  
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Fig. III-4.  Predicted chemical structures of Products 2 and 5.  Exact theoretical mass of both 
products = 1568.27.  Predicted mass for quadruply protonated species = 1572.30. 
 
52 
 
 
 
 
 
 
 
Fig. III-5.  MALDI-TOF mass spectrum of gel-purified Product 5.  Previously measured 
mass for GCCU-Phe = 1425.19. 
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Fig. III-6.  Product 5 has two free amino groups.  A: Gel-purified Product 5 yields two unique 
products when reacted with Sulfo-NHS-LC-biotin.  Band A = Product 5, B = Product 5 + 1 
biotin, C = Product 5 + 2 biotin, D = biotinylated Product 2, E = biotinylated Product 1.  B: 
Products 1 and 2 have one free amino group.  Reactions were performed at 4o C and contained 
4.6 mM EZ-LinkTM Sulfo-NHS-LC-biotin (Thermo Fisher), 0.1 M HEPES pH 8.0, ~10,000 cpm 
gel-purified product. 
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III-7A), as does Product 2 (Fig. III-7B). When gel-purified Product 5 was hydrolyzed, it decayed 
first to Product 1, and then to GCCU; first one RNA-Phe ester bond hydrolyzes to result in 
GCCU-Phe, and then the other (Fig. III-7C).  Taken with the leucine aminopeptidase, mass  
spectrometry, and biotinylation data, these observations support the conclusion that Product 5 is 
bis(2′, 3′-O-phenylalanyl)-GCCU. 
 The rates of ester hydrolysis offer further insight into the nature of the acylated products.  
The first order rate constant of hydrolysis can be measured from the negative slope of the line of 
the natural log of the fraction product versus time.  The hydrolysis rate constant measured for 
Product 1, 0.0345 min-1 (Fig. III-8A), is consistent with the published rate constant for tRNA-
Phe esters, 0.042 min-1 (Chousterman et al. 1966).  The rate constant for Product 2, 0.0319 min-1 
(Fig. III-8B), is very close to that of Product 1, which is somewhat surprising, since peptidyl-
RNA esters are generally more stable than aminoacyl-RNA esters (Gilbert 1963).  Activated 
dipeptides, however, are susceptible to cyclic dipeptide, or diketopiperazine, formation (Purdie 
and Benoiton 1973).  Product 2 is likely susceptible to not only base-catalyzed hydrolysis, but 
also loss of Phe-Phe in the diketopiperazine form, leading to an apparent rate enhancement for 
hydrolysis. 
 The observed rate constant for ester hydrolysis for Product 5, 0.0323 min-1, is similar to 
that of Products 1 and 2 (Fig. III-8C).  This is also surprising, since RNA diesters are generally 
more stable than monoesters, due to the absence of a destabilizing free hydroxyl group (Wang et 
al. 2006).  However, since Product 5 is susceptible to attack by –OH at both the 2′- and the 3′- 
hydroxyl groups, this rate constant is actually the sum of the hydrolysis rate constants for the 2′ 
and 3′ esters.  If hydrolysis at 2′- and 3′-OH is assumed to be equivalent, then the actual rate 
constant for hydrolysis for each hydroxyl group must be one-half the observed rate constant, or  
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Fig. III-7.  Gel autoradiograms of hydrolysis of gel-purified Products 1, 2, and 5.  Relevant 
product numbers are indicated beside gels. 
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A                                                                     B 
 
 
C 
 
 
Fig. III-8.  Hydrolysis rates of gel-purified Products 1, 2, and 5.  A: purified Product 1.  B: 
purified Product 2.  C: purified Product 5.  Squares = Product 1, Circles = Product 2, Triangles = 
Product 5.  First-order rate constants are equal to the negative slope of the line of through the 
natural log of the fraction product vs. time.  Hydrolysis conditions: 37o C, pH 8.5. 
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0.0162 min-1.  Therefore, Product 5 represents a stable reservoir of activated amino acids, since it 
takes twice as much time for the RNA-Phe esters to be depleted than for monoesters. 
Interestingly, there is a small amount of Product 2 evident in the gel after Product 5 
purification.  This could be indicative of intramolecular peptide bond formation, wherein a 
phenylalanine on one terminal hydroxyl group could attack the phenylalanine on the neighboring 
hydroxyl group of the same ribose, forming RNA-Phe2.  Quantitation of the amount of Product 2 
throughout the course of the reaction, however, indicates that this is not the case.  The amount of 
Product 2 does not increase, but rather decreases as it is degraded to GCCU with a rate constant 
of 0.0342 min-1 (Fig. III-8C).  In addition, other experiments with RNA-Phe diesters indicate that 
this intramolecular reaction does not occur (Wang et al. 2006).  Therefore, it seems likely that 
the residual Product 2 present at the beginning of the reaction is due to contamination from the 
gel purification of Product 5. 
 The next step was to determine if the remaining uncharacterized higher products are also 
RNA diesters, or variations on diesters.  To test this, I conducted a reaction under conditions 
conducive to higher product formation, using the GCCU 3′-deoxy derivative GCCU3′dU.  This 
derivative allowed monoester products to form, but did not allow for significant diester (Products 
5-8) formation, since it lacks one terminal hydroxyl group (Fig. III-9).   
 A faint band appears in the GCCU3′dU experiment approximately where one would 
expect Product 5, however.  This could be the result of ribose contamination in the 3′-
deoxyuridine used to synthesize GCCU3′dU.  Alternatively, Product 5 could in fact be a mixture 
of GCCU-(Phe/Phe) and a small amount of GCCU-Phe5 (see Chapter IV).   
 Products 5-8, then, appear to be dependent on the terminal 3′-hydroxyl group for 
formation.  Since Product 5 has been identified as RNA-(Phe/Phe), and it has been previously  
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Fig. III-9.  GCCU 3′-OH facilitates higher product formation.  Reaction conditions: 20 µM 
GUGGC, 10 µM RNA substrate, 100 mM KCl, 5 mM MgCl2, 0.1 M HEPES pH 7.0,  13.10 mM 
PheAMP, incubation at 4o C for 30 min. 
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demonstrated that RNA-peptides form in the presence of GUGGC, it seems likely that Products 
6-8 are peptidyl extensions of the RNA-Phe diester. 
Characterization of products: hydrolysis and peptidase treatment 
 Gel-purified Products 6 and 7 were hydrolyzed under the same conditions used 
previously.  Product 6 degraded to both Products 1 and 2, followed by GCCU (Fig. III-10).  
Therefore, Product 6 is likely RNA-Phe diester with two phenylalanines on one hydroxyl group 
(as in Product 2), and one on the other (as in Product 1), GCCU-(Phe/Phe2).  Product 6, then, has 
the same number of phenylalanines (three) as Product 3, but does not migrate the same distance 
on the gel due to its different number of free amino groups and different structure. 
 Since Product 6 decays to both Products 1 and 2, it possesses two hydrolysis rate 
constants, which can be estimated by fitting data from the above reaction to integrated 
degradation schemes calculated by Twente-Sim (Controllab Products, Netherlands).  The rate 
constant for hydrolysis from Product 6 to Product 2 (kh62) is 0.0065 min-1 (Fig. III-11), which is 
expected due to the enhanced stability of diesters as compared to monoesters (Wang et al. 2006).  
However, the rate constant for hydrolysis of Product 6 to Product 1 (kh61), 0.09 min-1, is higher 
than those for RNA-Phe and RNA-Phe2 individually.  One possible explanation for this is that 
the free amino group on the single Phe of Product 6 may positively influence diketopiperazine 
formation of, or otherwise destabilize, the opposing RNA-Phe2 ester. 
 When Product 7 was hydrolyzed, it decayed primarily to Products 2 and 3, followed by 
GCCU (Fig. III-12).  From this observation, one might conclude that Product 7 possesses five 
phenylalanines, with three on one hydroxyl group and two on the other.  This conclusion, 
however, leaves diester products with four phenylalanines unaccounted for. 
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Fig. III-10.  Product 6 hydrolyzes to Products 1 and 2.  Cartoons depict structures of products: 
sticks indicate terminal 2′/3′ end of RNA; balls indicate phenylalanine.  Phenylalanines are 
linked to RNA through ester bonds, and to each other through peptide bonds.  Gel by M. 
Illangasekare. 
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  kh61 = 0.09 min-1 
 
 
  
  kh62 = 0.0065 min-1 
 
 
 
 
Fig. III-11.  Hydrolysis of gel-purified Product 6.  A: Quantitation of product amounts over 
time.  Squares = Product 1, circles = Product 2, diamonds = Product 6.  B: Calculated rate 
constants for Product 6 hydrolysis.  Hydrolysis to Product 1= kh61, and to Product 2= kh62. 
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Fig. III-12.  Product 7 hydrolyzes to Products 1, 2, and 3.  The two forms of Product 7 (A and 
B) hydrolyze to the products depicted directly below the respective structures. 
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Quantitation of the Product 7 hydrolysis gel reveals a small amount of Product 1 
emerging over time (Fig. III-13A inset).  Product 7, then, is likely a mixture of two kinds of 
diester products with four phenylalanines.  One form of Product 7 has three phenylalanines on 
one hydroxyl group and one on the other (Fig. III-12, structure A), and the other form has two 
phenylalanines on each hydroxyl group (Fig. III-12, structure B).  Both these compounds have 
the same molecular weight and the same number of free amino groups, and would thus likely 
migrate the same distance in a gel. 
 The prediction for the structure of Product 7 is confirmed by the hydrolysis rates of the 
different products.  Hydrolysis of the Phe3/Phe1 form of Product 7 to Product 1 (kh71), for 
example, is slower than the rate of hydrolysis of that product to Product 3 (kh73) (Fig. III-13).  
This is because RNA-peptide esters are more stable to hydrolysis than RNA-amino acid esters.  
The rate constant for purified Product 3 hydrolysis, for example, is 0.011 min-1,  approximately 
one-third the rate of Product 1 hydrolysis (Fig. III-14).  Thus, the GCCU-Phe3 ester is more 
stable than the GCCU-Phe1 ester in Product 7, which is why Product 7 hydrolyzes to Product 3 
more quickly than to Product 1.   
 Following with the progression of three phenylalanines for Product 6 and four for 
Product 7, degradation of Product 8 confirms its identity as GCCU + five phenylalanines.  
Product 8 degrades to Products 1, 2, 3, and 4, which is consistent with its predicted structures of 
GCCU-(Phe4/Phe) and GCCU-(Phe3/Phe2) (Fig. III-15).  Just as for Product 7, the peptidyl-RNA 
ester bonds in Product 8 hydrolyze relatively slowly; for example, the GCCU-Phe4 bond 
hydrolyzes with a rate constant (kh81) of 0.001 min-1 (Fig. III-16).  This low rate constant reflects 
the stability of peptidyl-RNA diesters, even more so than peptidyl monoesters. 
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kh71 = 0.0014 min-1 
 
 
 
kh73 = 0.0086 min-1 
 
 
 
 
 
 
kh72 = 0.016 min-1 
 
 
 
Fig. III-13.  Hydrolysis of gel-purified Product 7.  A: Quantitation of product amounts over 
time.  Squares = Product 1, circles = Product 2, triangles = Product 3, diamonds = Product 7.  
Inset = Product 1.  Conditions: 37o C, pH 8.5.  B: Calculated rate constants for Product 7 
hydrolysis.  Hydrolysis to Product 1= kh71, to Product 2 = kh72, and to Product 3 = kh73. 
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Fig. III-14.  Hydrolysis of gel-purified Product 3.  A: Gel autoradiogram of Product 3 
hydrolysis.  B: Quantitation of gel. 
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Fig. III-15.  Product 8 hydrolyzes to Products 1, 2, 3, and 4.  The two forms of Product 8 
hydrolyze to the labeled lower products. 
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kh81 = 0.001 min-1 
 
 
 
kh84 = 0.003 min-1 
 
 
 
 
kh82 = 0.017 min-1 
 
 
 
kh83 = 0.028 min-1 
 
 
 
 
 
Fig. III-16.  Hydrolysis of gel-purified Product 8.  A: Quantitation of product amounts over 
time.  Squares = Product 1, circles = Product 2, triangles = Product 3, stars = Product 4, 
diamonds = Product 8.  Inset = Product 1.  Conditions: 37o C, pH 8.5.  B: Calculated rate 
constants for Product 8 hydrolysis.  Hydrolysis to Product 1= kh81, to Product 2 = kh82, to Product 
3 = kh83, and to Product 4 = kh84. 
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For example, this can be compared to a hydrolysis reaction of purified Product 4, GCCU-
Phe4.  Product 4 hydrolyzes with a rate constant of 0.01 min-1, which is comparable to the 
relatively slow hydrolysis rate constant for the RNA-peptide Product 3 (Fig. III-17).  Product 4 
hydrolyzes directly to GCCU; the other, lower products evident on the gel (likely a result of 
contamination from gel purification) do not increase in concentration as the reaction proceeds.  
Product 4, then, is GCCU-Phe4 peptidyl-RNA.   
 Each purified product was then treated with leucine aminopeptidase to determine which 
peptide bonds were present.  Products 2, 3, and 4 were all digested to progressively lower 
products, and eventually to Product 1, over time (Fig. III-18).  Therefore, Products 1, 2, 3, and 4 
are all related to one another through peptide bonds between phenylalanines.  Products 6, 7, and 
8 hydrolyzed progressively to Product 5, GCCU-(Phe/Phe).  These products, then, are peptidyl 
extensions of Product 5, or peptidyl diesters.  All these observations are consistent with the 
proposed product structures from the hydrolysis experiments. 
 
Discussion 
 The ability of an RNA molecule to esterify two amino acids to a substrate may have 
provided an evolutionary advantage in the RNA world.  RNA diesters are more stable than 
monoesters (Wang et al. 2006), and even if one ester bond hydrolyzes, there is still another 
activated amino acid remaining on the RNA.  The behavior of the Thermus thermophilus 
phenylalanyl-tRNA synthetases supports this idea, since T. thermophilus lives at extremely high 
temperatures, and may use its di-acylating ability to enhance the stability of its acylated tRNAs 
(Stepanov et al. 1992).   
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Fig. III-17.  Hydrolysis of gel-purified Product 4.  A: Gel autoradiogram of Product 4 
hydrolysis.  B: Quantitaion of gel.  Gel by M. Illangasekare. 
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Fig. III-18.  Digestion of gel-purified products with leucine aminopeptidase. LAP = leucine 
aminopeptidase, 23 ng/µl.  Gel by M. Illangasekare. 
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Most modern AARS have evolved to react exclusively with either the 2′- or 3′-hydroxyl 
groups of their cognate tRNAs.  In addition, the ribosome only uses the 3′-acylated tRNA isomer 
in the A-site as a substrate for peptide bond formation (Taiji et al. 1985).  Clearly, specificity 
(and hence suppression of transacylation) for particular isomers has emerged as an important 
feature of life as we know it.  Before proteins existed, however, when life was less complex and 
biological syntheses less efficient, specificity may have been less important, with resources 
instead concentrated on production.  Therefore, synthesis of many activated amino acids, 
catalyzed by enzymes with little information content, might have played a role in early biology. 
Here we have an example of a relatively unstructured active site, which allows for the 
formation of a variety of products.  This phenomenon has been observed previously; a 95-mer 
self-acylating ribozyme was found to add a second dipeptide to its first acylated product, creating 
RNA-Phe2, only after it had been minimized to a 29-mer ribozyme (Illangasekare et al. 1995, 
Illangasekare and Yarus 1999).  Therefore, once the structure of the ribozyme was simplified, its 
catalytic repertoire was increased.  Thus, enzymes with little information content can catalyze 
the formation of multiple products; in the case of GUGGC, the number of different products 
synthesized exceeds the number of informational units that make up the ribozyme. 
 The synthesis of peptide products from GUGGC/GCCU presents an interesting 
mechanistic problem. The predicted model for Phe-RNA synthesis (as determined by molecular 
dynamics and mutational analyses) from C3 predicts direct interactions between the overhanging 
GU of GUGGC, the 2′-OH of the 3′-terminal U of GCCU, and PheAMP (Chumachenko et al. 
2009).  Sterically, it seems that it would be difficult, if not impossible, for the overhanging GU to 
interact with the amino group of Phe the same way it interacts with 2′-OH, particularly if that 
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amino group is several amino acids away (for example, in the conversion of Product 3 to Product 
4).  
 The observed formation of diesters, however, is consistent with our model of acylation.  
Both the model of the CR mechanism (Chumachenko et al. 2009) and experiments with the 2′- 
and 3′-deoxy derivatives of GCCU indicate that GUGGC exclusively acylates the 2′-OH.  Once 
the 2′-OH is acylated, phenylalanine can migrate to the 3′-OH, and the 2′-OH can then be 
acylated a second time.  The model does not predict interference by 3′-OH, and therefore the 
presence of phenylalanine on 3′-OH may not affect the enzyme-catalyzed reaction. 
 In the following chapter, I will investigate how peptide bond formation occurs in the 
context of GUGGC/GCCU, and outline a mechanistic model for the formation of all the 
observed products. 
 
Methods 
Acylation and LAP assays 
RNA labeling, leucine aminopeptidase reactions, mass spectrometry, and gel 
electrophoresis were carried out as in Chapter II.  Aminoacylation assays were conducted as 
previously, but with modifications to conditions where indicated.   
Product purification 
Products were purified after gel electrophoresis by exposing radioactive gel to Kodak X-
OMAT Blue film, developing with a Kodak X-OMAT 2000A Processor, and excising the 
relevant bands.  For products to be used for mass spectrometry, cold reactions were run in 
adjacent lanes to hot reactions, and then excised according to the position of the radiolabeled 
bands.  Bands were crushed, mixed with water for 1 hour at 4o C, filtered, and lyophilized.  
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Gel-purified Product 5 was further purified using high performance liquid 
chromatography (HPLC) for hydrolysis and mass spectrometry experiments.  HPLC used a 
Waters Atlantis® T3 column (5µm) and the following gradient: 95% water/5% acetonitrile for 
10 min, ramp to 100% acetonitrile for 10 min, hold for 10 min, ramp to 95% water/5% 
acetonitrile for 10 min.  Fractions were collected (1 ml/min) and radioactivity was quantitated 
using a scintillation counter.  Fractions with high cpm (or cold fractions analyzed in parallel) 
were pooled and lyophilized.   
Calculation of hydrolysis rate constants 
Hydrolysis rate constants were calculated by fitting quantitated hydrolysis data to 
integrated degradation mechanisms calculated by Twente-Sim v. 2.3 (Controllab Products, 
Netherlands).  
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CHAPTER IV  
MECHANISTIC ANALYSIS OF PRODUCT FORMATION FROM GUGGC/GCCU 
 
Introduction 
 Extant peptide synthesis is a highly efficient and accurate process.  Peptide bond 
formation occurs between two amino acids, which are esterified to their cognate tRNAs and 
recruited to the ribosome when their codons are read from messenger RNA.  However, before 
the emergence of the genetic code (and the ribosome as we know it), short peptides may have 
formed in a different manner.  
 Previously, Zhang and Cech described a ribozyme which synthesized an RNA-dipeptide 
from Phe-RNA and biotinylated MetAMP (Zhang and Cech 1997; Gottlieb 2003).  Similarly, a 
29-mer ribozyme synthesizes RNA-Phe2 when reacted with PheAMP (Illangasekare and Yarus 
1999).  While both these ribozymes use substrates which are more reactive than the aminoacyl 
esters used for peptide synthesis in the modern translation system, their activities raise the 
possibility that dipeptides, at least, could have been synthesized from highly activated amino 
acids during the RNA world. 
 In this work, I have shown that peptide formation up to Phe5 has been observed in the 
presence of the ribozyme GUGGC, GCCU and PheAMP.  While the simplicity of the ribozyme 
and the length of the peptide chain suggest a catalytic advantage over the previously 
characterized ribozymes, the mechanism of peptide bond formation in this case is puzzling, since 
it would be sterically difficult for the GUGGC enzyme, while base paired to GCCU, to mediate 
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the addition of phenylalanines far from the active site of RNA-Phe ester formation.  Production 
of the initial RNA-Phe product has been shown to require the ribozyme, but the experiments 
shown thus far have not determined whether subsequent peptide bond formation is enzyme-
catalyzed or spontaneous. 
 The previously characterized dipeptide-forming ribozymes, as well as most other 
ribozymes isolated using SELEX (Joyce 1989, Tuerk and Gold 1990, Ellington and Szostak 
1990), are not true enzymes, since they can only catalyze a single-turnover reaction.  GUGGC, 
however, is expected to demonstrate turnover kinetics, since it associates reversibly with the 
substrate GCCU through hydrogen bonds.  In other words, each mole of enzyme should be able 
to catalyze the formation of more than one mole of acylated RNA product.  This phenomenon 
has not been observed in previous experiments, however, likely because the reaction conditions 
were not optimized for turnover. 
 GUGGC, then, possesses a possible advantage over other acylating ribozymes, but only if 
its mechanisms of action are understood.  In this chapter, I elucidate the mechanism of peptide 
bond formation, as well as the kinetic parameters for the catalyzed reactions.  The rate constants 
for acylation and peptide bond formation are determined, and turnover is demonstrated.  Finally, 
I present a mechanistic model for the formation of all products formed from GUGGC/GCCU, 
and discuss implications for RNA acylation and peptide bond formation in the early RNA world. 
 
Results 
Acylation kinetics 
 Since all products are dependent on the initial formation of Product 1, GCCU-Phe, the 
rate of 2′-acylation can be calculated by quantitating the amount of all products formed over 
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time.  These values can then be analyzed by Twente-Sim (Controllab Products, Netherlands), 
which will calculate a best least-squares fit curve by trying different values for kf.  Simplified 
product formation in the programmed model, which accounts for hydrolysis of PheAMP, will 
proceed as follows: 
 
                                                                           kf 
GCCU + FA → GCCU-F + A 
                                                           ↓kh 
                                                                   F + A,  
 
where GCCU = substrate RNA, FA = PheAMP, GCCU-F = acylated product, A = AMP, and F = 
Phe.  The rate constant for hydrolysis of PheAMP, kh, was found to be 0.0273 min-1.  This was 
calculated by quantitating the decay of PheAMP under standard acylation conditions, as 
measured by high performance liquid chromatography. 
Using the above equations and Twente-Sim, I found kf to equal 1.09 M-1 min-1 for a 
standard reaction of 12 uM GUGGC, 24 uM GCCU, and 3.9 mM PheAMP at pH 7.0 (Fig. IV-
1A).    Spontaneous acylation in the absence of GUGGC occurs at a low rate, with a rate constant 
of 0.071 M-1 min-1 (Fig. IV-1B), calculated by the same method (but with a relatively high error 
due to the low amount of product used for quantitation).  Therefore under these conditions, the 
ribozyme accelerates the acylation reaction 15-fold. 
 This estimate of k2, however, is not a measurement of kcat, since it does not take into 
account the association of the RNA enzyme and substrate strands.  In order to determine kcat, the 
system can be viewed as a classical multisubstrate enzyme acting through an ordered bi bi 
mechanism (Segel 1976).  In this situation, an enzyme first forms a complex with one substrate,  
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Fig. IV-1.  Calculation of kf using Twente-Sim.  A: reaction in presence of 12 µM GUGGC.  
Black = experimental data, grey = calculated data using kf = 1.09 M-1 min-1.  B: spontaneous 
reaction without GUGGC.  Black = experimental data, grey = calculated data using kf = 0.071 
M-1 min-1.   
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and then this complex associates with a second substrate (Scheme IV-1).  Once all three 
components are present, transition state and product formation can occur. 
 
 
 
Scheme IV-1.  Ordered bi bi mechanism for reaction of GUGGC, GCCU and PheAMP.  
Colons indicate transient interactions, i.e. hydrogen bonds. 
 
 By definition, this reaction should obey Michaelis-Menten kinetics, following the 
equation: 
                                          v  =                     vmax [FA]   
                                                        KFA(([Ro]+KS)/[Ro]) + [FA] 
 
where, for readability, Ro = GUGGC and [Ro]>>[GCCU].  KS is the dissociation constant (Km) 
for the interaction of GUGGC and GCCU, and KFA is the Km for interaction of PheAMP with the 
RNA complex (adapted from Segel 1976).  This equation has the same form as the standard 
Michaelis Menten equation: 
 
v =   vmax [S] 
                                                                           Km + [S]  , 
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but with Km dependent on KS, KFA, and Ro.  The parameters vmax and Km can normally be 
determined by measuring reaction velocities at a number of different substrate concentrations 
and plotting v vs. v/[S] (an Eadie-Hofstee plot).  This plot allows for a straightforward 
determination of vmax and Km, and does not crowd values close to the y-axis as in a standard 
double recriprocal plot  Since the GUGGC/GCCU equation contains two substrates and two 
Km’s, we can determine these parameters by measuring the apparent vmax and Km for two 
separate situations: one with constant [FA] and varying [Ro], and one with constant [Ro] and 
varying [FA] (Fig. IV-2). 
 Using this approach, we can calculate the values for vmax, KS, and KFA (see Methods for 
further explanation and calculations): 
vmax = kcat = 0.12 ± 0.028 min-1 
KFA = 6.4 ± 2.2 mM 
KS = 7.4 ± 4.3 µM 
kcat/Km for acylation = kcat/KFA = 19 M-1 min-1. 
Enzyme turnover 
The same conditions that cause the formation of the diester products also allow for 
turnover of the GUGGC enzyme, when the enzyme:substrate ratio is 1:10.  Under high PheAMP 
concentration (10 mM) and increased pH (7.5), the reaction yields a five-fold molar excess of all 
products compared to the enzyme (Fig. IV-3).  At pH 7.0, the reaction yields a four-fold molar 
excess at the same time point.  Therefore, each enzyme oligonucleotide is reacting with multiple 
substrate RNAs, remaining reactive itself after the first reaction has taken place. This shows 
unequivocally that GUGGC is a true enzyme, the smallest known ribozyme capable of 
aminoacylation of an RNA substrate. 
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B 
 
Fig. IV-2.  Eadie-Hofstee plots of GUGGC/GCCU reactions with trace GCCU.  A: varying 
[PheAMP], 10 µM GUGGC; B: varying [GUGGC] (Ro), 2.7 mM PheAMP.  All reactions were 
at 4o C and contained 100 mM KCl, 5 mM MgCl2, 350 mM HEPES pH 7.0, trace GCCU.  In a 
standard Eadie-Hofstee plot, y-intercept = vmax and slope = -Km. 
81 
 
 
 
 
 
 
 
Fig. IV-3.  GUGGC/GCCU turns over.  Reaction conditions: 10 µM GUGGC, 100 µM GCCU, 
100 mM KCl, 5 mM MgCl2, 0.1 M HEPES, 10.3 mM PheAMP, 4o C.  Squares = pH 7.0; circles 
= pH 7.5. 
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Peptide bond formation 
 To investigate the role of the ribozyme GUGGC in the formation of  the peptidyl-RNA 
products, Product 1 was gel-purified and re-reacted with PheAMP, in the presence and absence 
of GUGGC.  Interestingly, Product 1 was extended to Products 2-4 in both the presence and the  
absence of the ribozyme (Fig. IV-4).  Therefore, peptide bond formation in this scenario is not 
dependent on the ribozyme; it is spontaneous.  In fact, formation of Products 2-4 from purified 
Product 1 is more rapid when there is no ribozyme present (Fig. IV-5).  This indicates that a less 
constrained RNA substrate is a better candidate for peptide extension.  The diester Products 5-8 
only form in the presence of the ribozyme, which is consistent with the model for ribozyme-
dependent 2′-acylation following 2′→3′ transacylation. 
 When Products 2 and 3 were purified and reacted with PheAMP, peptidyl diester 
products (Products 6-8) were not formed in appreciable amounts, even in the presence of 
GUGGC (Fig. IV-4).  This indicates that ribozyme-catalyzed 2′-acylation of 3′-peptidyl products 
is slow or absent, possibly due to steric hindrance from the 3′-peptides; therefore, all peptidyl 
diester products first require the formation of Product 5. 
 A small amount of Product 5 can be seen from the reaction with purified Product 2 and 
GUGGC; this is likely the result of acylation of residual Product 1, a contaminant from gel 
purification (Fig. IV-4).  However, a greater amount of Product 5 results from the re-acylation of 
Products 3 and 4, even in the absence of GUGGC.  This indicates that spontaneous peptide bond 
formation may continue to lengths of up to five phenylalanines, resulting in the product GCCU-
Phe5.  Therefore, Product 5 may be heterogeneous, consisting primarily of the RNA-diester, but 
with a smaller amount of GCCU-Phe5 migrating to the same point in the gel. 
 This can be further demonstrated with an additional experiment with the RNA substrate 
derivative GCCU3′dU.  When this substrate was reacted with GUGGC and PheAMP, four initial  
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Fig. IV-4.  Re-acylation of gel-purified products.  Conditions: 0 or 10 µM GUGGC, 100 mM 
KCl, 5 mM MgCl2, 7.0 mM PheAMP, 4o C, 0.1 M HEPES pH 7.0.  Gels by M. Illangasekare. 
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Fig. IV-5.  Quantitation of re-acylation of Product 1.  Triangles = 10 µM GUGGC, squares = 
no GUGGC.  Conditions as in Fig. IV-4. 
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products formed, as well as a trace amount of a fifth product (Fig. IV-6).  This barely visible 
product disappeared upon treatment with leucine aminopeptidase, which indicates that it was 
RNA-Phe5.  As the LAP reaction progressed, another, just detectable product emerged at  
approximately the same position as that fifth product.  This product is likely the diester, the result 
of degradation of a low level of peptidyl-diester products made possible by trace levels of ribose 
contamination from 3′-deoxyuridine. 
 Spontaneous peptide bond formation in this system proceeds more rapidly than in a 
system containing acyl adenylate alone.  Here, the second order rate constant for peptide 
formation from GCCU-Phe to GCCU-Phe2 (in the presence of PheAMP), for example, is 
calculated to be 6.3 M-1 min-1 (Fig. IV-7), compared to ~0.3 M-1 min-1 for alanyl adenylate alone 
(extrapolated from Lewinsohn et al. 1967).   Polymerization of alanyl adenylate, however, was 
found to proceed by means of attack of free alanine on AlaAMP, a relatively slow reaction.  In 
the case of RNA-Phe, the pKa of the attacking amino group should be much lower than that of 
free amino acid (Phe methyl esters have an amino group pKa ~2 pH units lower than Phe 
(Almond et al. 1959)).  Therefore, the phenylalanyl amino moiety of RNA-Phe is likely to attack 
PheAMP under our conditions, leading to rapid polymerization to RNA-Phen>1.  Thus, although 
peptide bond formation in this case is not directly ribozyme-catalyzed, both GUGGC and GCCU 
are required to enhance amino acid nucleophilicity and drive the reaction. 
Model of product formation 
 We now can formulate a model for the formation of all products, which is depicted in 
(Scheme IV-2).  Chemical structures for products are depicted in (Fig. IV-8).  First, GUGGC and 
GCCU associate, with a Km of 7.4 ± 4.3 µM.  Next, PheAMP associates with the RNA complex, 
with a Km of 6.4 ± 2.2 mM.  Ribozyme-catalyzed acylation of the 2′-OH of GCCU from  
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Fig. IV-6. Product 5 is an RNA-diester and an RNA-peptide.  Acylation conditions: 20 µM 
GUGGC, 10 µM GCC3′dU, 100 mM KCl, 5 mM MgCl2, 0.1 M HEPES pH 7.0,  9.6 mM 
PheAMP, incubation at 4o C for 75 min.  LAP = leucine aminopeptidase, 23 ng/µl; incubation at 
pH 7.0, 37o C.  Arrows indicate forms of Product 5. 
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Fig. IV-7.  Calculation of rate constant for peptide bond formation.   Black = experimental 
data from quantifying the formation of Product 2 + Product 3.  Conditions: 12 µM GUGGC, 24 
µM GCCU, 3.9 mM PheAMP, 100 mM KCl, 5 mM MgCl2, 0.1 M HEPES pH 7.0, 4o C.  Grey = 
data calculated by Twente-Sim at the least-squares best rate constant of k = 6.3 M-1 min-1. 
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Scheme IV-2.  Schematic of forward reactions.  Bars on sticks portray 2′ (top) and 3′(bottom) 
hydroxyl groups of GCCU terminal uridine; F is phenylalanine.  S = strand association; T = 
transacylation; R = ribozyme-catalyzed aminoacylation.  All other arrows indicate spontaneous 
peptide bond formation from PheAMP.  Numerals below the structures indicate fractions from a 
polyacrylamide gel (as in Fig. IV-4); 1 = Product 1, and so on. 
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Fig. IV-8.  Chemical structures of all predicted products. 
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PheAMP then occurs with a kcat of 0.12 ± 0.028 min-1, forming Product 1a.  This can then 
undergo transacylation, resulting in Product 1b.  Products 1a and 1b can then react with PheAMP 
spontaneously, resulting in Products 2, 3, and 4, and to a lesser degree, Products 5b and 5c.   
Alternatively, Product 1b can be re-acylated at its 2′-OH, resulting in Product 5a.  Finally, 
Product 5a reacts spontaneously with PheAMP to form Products 6, 7, and 8.   
 
Discussion 
 The kinetic parameters for GUGCC/GCCU can be used to compare the enzyme 
efficiency with other aminoacylating ribozymes.  kcat/Km for GUGGC/GCCU is about 21% of 
that for a 29-mer self-acylating ribozyme (kcat/Km = 87 M-1 min-1 at pH 7.0 and 0o C) 
(Illangasekare et al. 1999).  The 29-mer also apparently catalyzes peptide bond formation with a 
second-order rate constant of 6.7 M-1 min-1 under the same conditions (assuming that peptide 
bond formation is log-linear with pH, as acylation is).  This rate constant is comparable to that 
for RNA-peptide formation in the presence of GUGGC, 6.3 M-1 min-1.  Since the 29-mer is self-
acylating, it is not clear whether peptide bond formation in that case is enzyme-catalyzed or 
spontaneous.  Therefore, peptide bond formation in the presence of GUGGC/GCCU is at least as 
rapid as with a more complex ribozyme, while acylation is somewhat slower. 
 Surprisingly, kcat  for acylation by GUGGC is only about 1% of kcat  for the parental C3 
ribozyme (assuming kcat at pH 7.0, 4o C ≈ kcat at pH 6.4, 15o C = 20 M-1 min-1) (Chumachenko et 
al. 2009).  Since the kinetics of C3 are non-Michaelian due to the formation of inactive RNA-
PheAMP complexes, a complete comparison of kinetic parameters between C3 and 
GUGGC/GCCU is not possible.  Comparison of only kcat, however, indicates that the extra 
secondary structure in C3 may accelerate acylation, though it does not allow for peptide bond 
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formation.  This phenomenon has been observed before; the 29-mer ribozyme acylates with a 
second-order rate constant 10% lower than its 95-mer parent, and unlike the 95-mer, hosts RNA-
dipeptide formation (Illangasekare et al. 1999).    
GUGGC does not catalyze RNA acylation as rapidly as does the protein aminoacyl-tRNA 
synthetase, which has a kcat for acylation of 960 min-1 at pH 7.0 and 21o C (Dibbelt and Zachau 
1981).  Compared to another transacylating ribozyme, however, GUGGC is quite efficient.  The 
AD02 ribozyme acylates tRNA using glutaminyl cyanomethyl ester with a kcat/Km of 12.34 M-1 
min-1 at pH 8.0 and 25o C (Lee et al. 2000).  This is an overestimate of the kcat/Km under standard 
GCCU conditions (pH 7.0 and 4o C), and is still only 65% of kcat/Km for GUGGC.  Therefore, 
while having more structure can sometimes contribute to rate accelerations, this is not always the 
case. 
 While GUGGC does not directly catalyze the formation of peptide bonds, it facilitates the 
formation of peptidyl-RNA products by first acylating the 2′-OH of the RNA substrate.  This not 
only activates the amino acid through its carboxyl group for further transfer, but also changes the 
nature of the amino acid’s amino group, making it a stronger nucleophile, prone to peptide bond 
formation.  Thus, very small RNAs may have played a role not only in “moderately” activating 
amino acids (aminoacyl esters are more stable than aminoacyl adenylates), but also in forming 
short peptides.  This model, however, does not explain how coded peptide formation from 
aminoacyl esters (as occurs today) could have arisen.  The following chapter will address this 
issue. 
 
Methods 
PheAMP hydrolysis calculation 
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 PheAMP hydrolysis was measured by injecting PheAMP (incubated for different times 
under standard acylation conditions) into an HPLC system and quantifying the area of the peak 
eluted at 9 min by measuring absorbance at A260.  PheAMP was eluted from a Waters Atlantis® 
T3 column (5µm) using a 90% 0.1 M ammonium acetate, pH 4.5/10% acetonitrile isocratic 
gradient.  The hydrolysis rate constant was calculated by taking the slope of the line of natural 
log (area PheAMP peak) vs. time. 
Kinetic calculations 
 Second-order rate constants for RNA acylation and RNA-peptide formation were derived 
by fitting experimental data to integrated reaction schemes calculated by Twente-Sim v. 2.3 
(Controllab Products, Netherlands) to provide best least squares fits. 
  To calculate the kinetic parameters vmax, KFA, and Km, we start with the equation: 
 
                   (1)                     v  =                     vmax [FA]   
                                                        KFA(([Ro]+KS)/[Ro]) + [FA] 
 
which is the Michaelis-Menten equation for an experiment with varying [FA].  We can first find 
the apparent vmax at saturating (mM) [FA], vappFA, experimentally.  vappFA, then, is the y-intercept 
of the Eadie-Hofstee plot in Fig. IV-2A, or 0.12 min-1. 
 From the same experiment, we can measure the apparent Km at varying [FA] (KappFA) by 
taking the slope of the line of the Eadie-Hofstee plot (13 mM).  KappFA is the Km for the standard 
Michaelis-Menten form of equation (1), and therefore has the equation: 
       
    (2)                      KappFA  =  KFA(([Ro] + KS)/Ro)  =  13 mM. 
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We can also rearrange equation (1) to take the form of a standard Michaelis-Menten 
equation for an experiment with varying [Ro]: 
 
      (3)                        v  =  vmax [FA]/(KFA+[FA]) [Ro] 
                                          (KFAKS/(KFA+[FA])) + [Ro] 
 
where the apparent vmax, vappR, can be measured from the y-intercept of the Eadie-Hofstee plot 
under varying [Ro] (Fig. IV-2B), and can be written (from the vmax term of equation (3)): 
 
                   (4)                      vappR  =  vmax [FA]/(KFA+[FA])  =  0.036 min-1  
We can also see from equation (3) that at saturating [FA] (i.e. as [FA] approaches 
infinity), the vmax term = vmax times 1.  Therefore, the vmax that was measured under varying 
[FA], vappFA, is the true vmax.  Since velocities here were measured in the form fraction 
reacted/min, vmax is also equal to kcat for acylation. 
The apparent Km for the reaction at varying [Ro], KappR, can also be calculated from the 
slope of the relevant Eadie-Hofstee plot and written as: 
                   (5)                      KappR  =   KFAKS/(KFA+[FA])  =  5.2 µM. 
 
We can then solve equation (4) for KFA, and find it to equal 6.4 mM.  Finally, we can solve 
equation (5) for KS, and find it to equal 7.4 µM.  Thus vmax, KS, and KFA have all been 
determined by variation of [Ro] and [FA] separately. 
Product purification for re-acylation 
Products were purified after gel electrophoresis by exposing radioactive gel to Kodak X-
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OMAT Blue film, developing with a Kodak X-OMAT 2000A Processor, and excising the 
relevant bands. Bands were crushed, mixed with water for 1 hour at 4o C, filtered, and 
lyophilized.  
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CHAPTER V  
SELECTION TOWARD A PEPTIDYL TRANSFERASE RIBOZYME 
 
Introduction 
 Since modern protein synthesis is dependent on the activity of proteins, the first peptides 
must have been synthesized by non-protein enzymes.  RNA is both capable of storing genetic 
information and catalyzing reactions, and therefore presents a likely candidate for the first 
protein synthetase.  Peptidyl transfer is today catalyzed by only the RNA component of the 
ribosome (Nissen et al. 2000), and so this reaction, in principle, should be attainable by 
ribozymes. 
 I have previously shown (Chapters II-IV) that short peptides can be synthesized in the 
presence of aminoacyl-RNA esters and activated amino acids (aminoacyl adenylates).  However, 
the peptides synthesized in these reactions are not assembled according to a coding mechanism; 
they arise from spontaneous reactions between aminoacyl adenylates and aminoacyl-RNAs.  The 
model for this peptide bond formation does not predict a correlation between the sequence of the 
RNA and the side chain of the amino acids in the peptide; peptide bond formation should be able 
to occur between any two activated amino acids.  In addition, activated amino acids have been 
shown to polymerize on mineral surfaces in the absence of a coding mechanism (Lambert 2008). 
 An important question, then, is how one can generate a specific sequence of amino acids 
from a particular RNA sequence, without the intervention of other proteins.  The Direct RNA 
Template (DRT) hypothesis predicts that this can be accomplished by aligning two activated 
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amino acids on an RNA template, which may facilitate peptide bond formation between the 
amino acids (Yarus 1998, Yarus et al. 2009).  For this model to be supported, there must exist, 
firstly, specific RNA sequences that will bind amino acids individually. 
 RNA “aptamers” which bind to eight amino acids have been found (Yarus et al. 2009) 
using Systematic Evolution of Ligands by Exponential Enrichment, or SELEX (Joyce 1989, 
Tuerk and Gold 1990, Ellington and Szostak 1990).  Therefore, the first requirement of the DRT 
theory has been supported.  In particular, aptamers for histidine (Majerfeld et al. 2005) and 
phenylalanine (Illangasekare and Yarus 2002) have been isolated and characterized, and found to 
bind their ligands with a high degree of specificity and affinity.  Interestingly, the His and Phe 
aptamers, like many other amino acid aptamers, have an unusually high number of codons and 
anticodons within their binding sites, which supports the idea that the genetic code may have 
arisen from direct stereochemical interactions between RNA and amino acids in the past. 
 Opponents of the DRT hypothesis have suggested that peptide bond formation could not 
have originated on a direct RNA template, since two amino acids bound to adjacent triplet 
codons could not contact each other sterically (Koonin and Wolf 2007).  They argue that RNA 
adaptors (proto-tRNAs) had to exist, as well as coding RNAs, from the beginning of the 
evolution of translation.  This idea, however, requires a mechanism to specifically charge proto-
tRNAs with particular amino acids, a highly complex process which would have been difficult 
during the early RNA world.  I propose that the codons or anticodons do not necessarily have to 
be adjacent for an RNA to bind a dipeptide, and thus the argument for steric constraints is not 
relevant. 
 Several groups have attempted to isolate a single RNA which will catalyze peptide bond 
formation from aminoacyl esters, but none have been successful (Jenne and Famulok 1998, 
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Zhang and Cech 1997).  These workers have relied on the conventional methods of finding 
aptamers to transition state analogues, or using substrates which are covalently bound to the 
ribozyme.  Here, I attempt to isolate an enzyme which truly works in trans, starting with RNA 
which will bind an already-formed dipeptide. 
 In this chapter, I will show that I was able to isolate a pool of RNAs which selectively 
bind the dipeptide His-Phe.  While tests for peptidyl transferase activity were inconclusive, these 
dipeptide aptamers support the DRT hypothesis, and thus offer a model for how the first peptidyl 
transferase ribozymes could have emerged. 
 
Results 
Parallel selections for His-Phe-binding RNA 
 Three selections were carried out in parallel in order to isolate RNA which would bind to 
all the following ligands: free histidine, free phenylalanine, and the dipeptide His-Phe.  All three 
selections used RNA with 60 random nucleotides flanked by primer sequences, which was 
labeled with 32P and applied to His-Phe-sepharose columns.  RNA was eluted from the columns 
and collected as indicated in (Table V-1).  Desired fractions from column chromatography were 
pooled, reverse transcribed, PCR-amplified, and transcribed back to RNA for the next cycle. 
These three selections were designed to avoid the selection of RNAs which would bind to 
His-Phe only by virtue of the fact that they bound His or Phe individually.  Previous experiments 
suggested that selection performed only by elution with the dipeptide (Selection I) may not 
succeed due to the high affinity of RNA for histidine.  Thus, the aim of Selection II was to 
remove strong His- and Phe-binders from the RNA pool, leaving RNAs which would bind His-
Phe with high affinity, and His and Phe with lower affinity.  In the event that Selections I and II 
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were unsuccessful, Selection III was designed to isolate RNAs that bound His, Phe, and His-Phe 
with relatively equal affinity. 
 
Selection  Cycle 1              Cycle 2              Cycle 3               Cycle 4               Cycle 5 
   +  ‐  +  ‐  +  ‐  +  ‐  + 
I  His‐Phe     His‐Phe     His‐Phe     His‐Phe      
II  His‐Phe  His, Phe  His‐Phe  His, Phe  His‐Phe  His, Phe  His‐Phe  His, Phe  His‐Phe 
III  His‐Phe     His     Phe     His‐Phe     His‐Phe 
 
Table V-1.  Column elution for His-Phe aptamer selections.  “-“ indicates RNA eluted after 
addition of compound(s) was discarded.  “+” indicates RNA eluted after addition of compound 
was collected and used for the next cycle. 
 
  
 All three selections yielded RNA which appeared to bind His-Phe.  This was first 
observed in Selection I, where 37% of the RNA was found to elute from the His-Phe-sepharose 
column upon addition of the dipeptide after only the fourth cycle (Fig. V-1A).  RNA from 
Selections II and III showed a response to His-Phe after the fifth cycle; 50% of the RNA eluted 
upon addition of 1.5 mM His-Phe in Selection II, and 49% in Selection III (Fig. V-1B, C). 
Binding characteristics of selected RNA 
 RNA from all three selections was tested for binding to free histidine and phenylalanine.  
Both RNA from Cycle 3, Selection I and Cycle 4, Selection III eluted from His-Phe columns 
upon addition of histidine, but not phenylalanine (Fig. V-2).  RNA from Cycle 4, Selection II 
showed a response to neither histidine nor phenylalanine.  Therefore, the strategy of discarding 
strong His- and Phe-binders from Selection II was effective.  While Selections I and III yielded 
RNA which binds His-Phe, it likely only binds through the His moiety, and thus may not be 
specific for the dipeptide. 
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Fig. V-1.  Elution profiles of RNA from His-Phe columns.  A: Selection I.  B: Selection II.  C: 
Selection III.  1.5 mM His (H), Phe (F), or His-Phe (HF) was applied to each column at the point 
indicated.  Numbers indicate the cycle in which the eluant was applied.  RNA was either 
discarded or collected as shown in Table V-1. 
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Fig. V-2.  RNA elution profiles from His-Phe columns upon addition of free His and Phe.  
1.5 mM His, 1.5 mM Phe, or 1 M NaCl/2 M EDTA/50 mM HEPES pH 7.0 were added where 
indicated. 
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To test the dipeptide-binding specificity of Selection II RNA, elution from a His-Phe 
column was attempted using variations of the His-Phe dipeptide: His-Gly, Gly-Phe, and Phe-His 
methyl ester (Phe-His-OCH3) .  RNA did not elute upon addition of any of the His-Phe variants, 
which shows that the RNA is likely contacting both amino acid moieties of His-Phe (Fig. V-3). 
Sequences of selected RNA 
RNA from the final cycle of all three selections was then reverse transcribed to DNA, 
amplified through PCR, cloned, and sequenced.  Analysis of the sequences from Selections I and 
III revealed the presence of the canonical His-binding site formerly characterized by Majerfeld et 
al. (2005) in 14/23 sequences for Selection I (Fig. V-4), and 25/41 sequences for Selection III 
(Fig. V-5).  Interestingly, most of the sequences which did not contain the canonical His site still 
contained both modules of the His site, but in a reverse orientation than was previously described 
(Module 1 is 3′ of Module 2).   
Therefore, while RNA from Selections I and III binds to His-Phe, the tendency of RNA 
to bind the imidazole group of histidine (Majerfeld et al. 2005) likely skewed the pool 
composition toward RNAs that bind histidine only, and have no response to phenylalanine.  
Attempted elution of RNA by phenylalanine in Cycle 3 of Selection III was apparently not 
sufficient to select for RNAs that bind both histidine and phenylalanine. 
 The pool RNAs from Selection II, however, do not appear to contain the previously 
characterized histidine-binding site, with the exception of clone 14 (Fig. V-6), which is 
consistent with the observation that they do not appear to bind histidine with high affinity (Fig. 
V-2A).   
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Fig. V-3.  Selection II RNA specifically binds the dipeptide His-Phe.  1.5 mM dipeptide 
variant and His-Phe were added to the His-Phe columns as indicated. 
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I_130      GAUUGCACUAGGUACAUUUUGCAAGGGGACAGAGGGUAAGAAUGUAUGAAACGGCCCCG 
I_111              AACAUGCAAAACGGGUUUGGNAAGAGGGAAAUAACGAUAGAAACAGCCUCNCGGACAUGC 
I_143              GCACAAGGGCGGGGACAGGCAAAGAGGGCGUAGAAGAGAGUAACAGGCCGCUCAACCCGG 
I_127                                  
GGGGCCAGGGGGAACGUGGGCAACAGCCCCGCUCAAAGGGUCACUGCGCAAGGCUGGAGU 
I_117                   UAGAGCAUGCAGUGGAAAGUGGGAUAGAACGUAGGUAACGGCCUCGACAUGCAGUAGGCG 
I_97                GGGGUGUUACGACUGGCGAAAAGGGGGUGUGAAUGUGAGCAACAUUUGCGGGUCGUGUGC 
I_133    CCAAAGGGGGGAAACGUGACUCCAAGCGCAGGGAGAUCAUAGGCAGUGAGGAACAGGG 
I_113                UGGGCGACCCGCGUGGAAAGGGGGGGAAUCAAAGUAAGUAACAGGUACGUUGGUUGCGGG 
I_100                    ACACCACAACCGGUCGAUAUAGGGGGAUAGUAAGUAACAGAUCGGCGGAAAAUCGGCGUA 
I_142             AUGUACAAACGAAAGGUCCUGAAGGGGGAUAUGGAUGAAAGUAACACAGGCCGUUGUUC 
I_125     AAAGGAAAAGAGGGAUGCGAUCGCUUUUUGGAGGCGUCGUAUACGUGGGUAACAGGCCGU 
I_131  GAACUGUAUCUCUUAUAAGUUCGGCCAAAAUCGGAAAGUGGGUUGAUGUAAGUAACAGGCGAUUUG 
I_103 UUGUGUUGAGUGUUCGACUCUGGACNCUAAAUCGGAAAGUGGGUUGAUGUAAGUAACAGACGAUGGC 
I_110                GGCAGUUUCGGUAAGGAGCAGAAAAAGAGGGAAGUAGGUAACAGUUCUGCGCGCAGUGCG 
 
His site: 5′ R A A G U G G G K K N(0-36) A U G U N(0-2) A G K A A C A G 3′ 
 
 
B 
 
I_135           ------UCAAUGGUACACAAUGUGAAA-GA-AAAGCGACCUGGAAGAUUUAAUUGUAAAUCGACUGCG 
I_144           ---AAUCGGAAGGGCCAGAAUUCCCAU-GACAAAUCAGCAUGUGAGG---AAUUGAAGAGCGGCGG-- 
I_120           ----GCGGCAAUGGCCAAAUCGGCCAC-GAUGGUAGGUAACAACCGAC--AAACGGGAAGCGGGGGC- 
I_101           ---CACGUAAAUGAAGGCAACAACGGU-UAUAACCCUGUCUGGGGUG---AACUAUAAGAGGGUGUG- 
I_124           ------CCAGAGGUUAGCAACAGACAC-AGCGGCCUAGUAAUGGGCCGUAUGCGGUAAAGUGGGGGG- 
I_122           GCCAAACGAUAGGAUAGUAACAACAUC-CGUGCAGUCGCCGGAUGGAA--GAGGGGAAAGUGG----- 
I_140           -----GCGUGAAGUUAGAAACAGGAUA-GUUGGGAUCACAGAGGACCG-AUCCAAGAGGGUAAUCGC- 
I_115           ---GCUAAAAACGAGAGGAACACCAUU-GAGAGAGAUGCGAAUUGCAUGCAAGUGGUAGCGGGU---- 
I_129           -------CCGAUGUUAUGGCCGGGAUCCUACAGCCGCGCUAAGAGUCAGGAGGUCGGACGGGGUAGG- 
                                                                            
                                                                            
 
 
Fig. V-4.  Clone sequences of RNA variable region from Selection I.  A: sequences containing 
canonical His-binding site.  B: ClustalW alignment of sequences not containing canonical His-
binding site.  Module 1 of His motif is highlighted in gray, Module 2 in black. 
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III_51             UACCCGUAGACGAAUGGAACAUGGCAGAGGGACGAAGAUAAAGAAACACCAUGGGGCGCG 
III_52                GCCUGCAUAAGUGGCCAGAUCAAAGCGGGUAAAUGA-AAGAAACAGGACUAGUACACUGGG 
III_66                   GCAGGCUGUCAACACUGAAAGCGGGUGUAAUGUAAAGAAACAUCAGUGAAUCGUGACGCG 
III_73                 CCGGUCAGGAUAACCAUGAAUAGAGGGAGGAAUGA-AAGGAACAGUCAUGGCCGGAGUGGG 
III_67                 GGAUAUGCACCCAAAAGAGCCAAGAGGGAUUAGGA-AAGUAACAGGUUUGGACCGGUGAGG 
III_49                  AAGGUGGUAAGGAGAAGCUUCAAGGGGGGUUUGAAUAGUAACGGGAGAUAUCCGGCCGUA 
III_50                     GCUGCUACUAAAAAUGCGCAAGGGGGUCUGU-UAGUAACAGCGCAGAACUAGAACGGCGGG 
III_72                 CUCAUGGGGCUGCGGGCAAAGUGGGAUAAAUAGGA--AGUAACAGGCCACAUUCUCCCCUGG 
III_63        CUGUAUGGAAGGGGGAAUGGGCUAAGACCCAGCAGGGGAAAUGU-GAGUAACAACAGCCGG 
III_70                GCAAAUGGAGCAAGGGGUGUCAAGUGGGGUAUUGGU--AGGAACAGGCAGGUUGCUCUGAGG 
III_65      CACGUCCAGACUAAAGGCUGUGGACCCAAUGGGGAAAGUGGGA-GC-AAGUAACAUCCCGGG 
III_93 GCAAAGUGGGGGUAGGCGAAUUGGAUUAUGCCCAGUUUGGUGUCUGCCAGU-AAGCAACAG 
III_76                      CUCCGACGGUCUAUAGGCAAGUGGGUAAGU-GAGUAACAGCCGUAACAAAAGUACCGUGCG 
III_88          CCGCAGCGCGAAGAGGGGCUGGCAUGAUACCGAAAGUUGAGU-GGGAAACAAGUGGCUGGG 
III_96                      GAGUAAGCGGCCUAGAAACCAGAGGGGUGU-AAGUAACAGUCAAAUCGGUCGGCAAUCGGG 
III_58                   GUGGCUCGCUAUUAGCUUGGUAGAGGGAUAGGA-AAGGAACAACAGGCUUAAGGAGAAUGG 
III_68               AGUCUGUGCUGAGAGAUUAGGCCUAGAGGGUUAAUGU-UAGGAACAGGCAAUCUAGCGCGG 
III_89                   GCAGUACCUGGUCCGUGAAGAGGGGGAUAAUGCUGAGUAACACGCGGAUCCUAAGGUGGU 
III_91                  GUUCCACCGGGCUAAGAAAGAGGGGGUGUGAUGU-UAGGAACGAUUCUGUCCUGGACGGCG 
III_95                    UCGGGUUCACGGAGGCACAGGGGGUUUGACGC-AAGGAACGGGCUGCAGGGAACAUAGUGG 
III_85                     CAUGAGACAGUAUAGACAAGUGGGAAUAUGU-GGGUAACAGUCUAUUUCUGAUAGUGCGGG 
III_62                   GCAGGUAUCAUCGGGACACCAGUGGGACGUAGU-GAGUAACAGUGUUUUCAGGUGGUGCGG 
III_61                   UGGUGUGGACGGAAUUAACAGUGGGCGUGGGGUUAGGUAACGGUAAGAUCUGUUGCGCGG 
III_83                 ACGACGUUACGGGAGUAAGCGCUAGUGGGAAUUGU-GAGUAACAGCGGAUCCCAGCUAUCG 
III_82    ACCAAGUGGGUAGGGUUUCGUGGAUGUUGUAAUGCUACUCAUUCGCGA-GGGUAACAGGUA 
 
His site: 5′ R A A G U G G G K K N(0-36) A U G U N(0-2) A G K A A C A G 3′ 
                       
 
 
B 
 
III_64          ----CAUUAUGGGGGAAACA-A--CGGCGAAACAAUGCUUCAU-GCAAAGUGGACCGGAAGUGGGCG-- 
III_90          ---GCAAUAUGUUGGGAACA-AU-CGACGAAGUUGUGAGCAUUAGUUUUAAGGUCGGGUAGGGGG---- 
III_78          --GGCAAAGAAACGGCUACA-UG-AAUUUGUAGCAAGGGGGUUAGCCAAUUUAUUGGGAUGCUG----- 
III_80          ---GCAGUAGGCGAGUAACA-G--CAACGGGUAUGGGGCAAGAAGUCCAUAGCCUUGGUAGUGGGG--- 
III_53          ----CGAUGAGUUGGGGGUA-AG-UAACAGAUG-AUACCUGGUCAUAAAGAGGGUCCAAUCUAAGCG-- 
III_60          GAUUAGAUGAAAGUAACGCG-GC-UUACGGGACUAAUACGAACAGUGAAGCUGCAGGGGGGU------- 
III_92          --GCGGAUAGGUGAGUAACA-G--CGAUGUUG--AUAGCAAUUUAUAACAGGAACGGCAAGUGGGCA-- 
III_55          ---GGCGAGCGAUGAGGGUA-GU-AACAGUUGGUUUAAUUGACAACAAGAGGGUAGUAGUGCCG----- 
III_69          -----GGUAUGUAGGGAACAUGG-UGCUACGGAUAAAACGGUAUUUAUCCGGGAACCAAAGUGGG---- 
III_56          --------AUGUUAGUAACACGG-AUCCCGAACGUUUGCGAAUGCGGACGCCGUCAGAUCCGAAGUGGG 
III_74          ---CAGAACUGUUAAUGAUAGGA-ACACUGUUGCCACCCAAGGACGCAGGAGCGGGUGAGGUCG----- 
III_77          ---GACACGGAAUGGUAACAGGUGCGCUAUUGACUAGACGCAGACCAAGUGGGGUGGCCCGUG------ 
III_79          -----GCCAUAGGAGGAAACGAAAUGUAGGAAACGGGCUAUAUGUCAAGGGGGACAACCUCGGUG---- 
III_71          -------CCGAAAGGUAACAACG--CACGGUGACACGAUUGUUACCGGCGGAAGUGGGUAUGGCUUCGU 
III_75          -------UGGAAACGUAACAUGGUGGAGGGUUAUAGGGUUUACUAUAGCCCGAUGCGAAAGUGGGGU-- 
III_59          ----GGCCGCAGGACGCGAAGGGCCGAGACGUGGUUCCGAGAUAGUGAUCGGGUGGGCUGGUGU----- 
 
 
Fig. V-5.  Clone sequences of RNA variable region from Selection III.  A: sequences 
containing canonical His-binding site.  B: ClustalW alignment of sequences not containing 
canonical His-binding site.  Module 1 of His motif is highlighted in gray, Module 2 in black. 
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                                                                                        No. of  
                                                                                       sequences 
 
II_02a ----------AAGAGUAAGGGAGGGGCUAACAAACGUGGCUGUCAUUU---GGAU--AUUUAGUGGGG--UUUGGUG----   1 
II_40* ----------AAGGGUA---GAUAUGC--GUAUAUGCAGAUCCCAAAUAAAGGACGAAUUUAGUACGG--GG-GGUGU---   2 
II_01* ----------AAGGGCA---GGUAUGC--GUAUGCGAGGCUAACAGAUCAUGAAGUAGAUUCGGAAUC--UGUGCCG----   3 
II_04b ----------AAGGGCA---GGUAUGC--GUAUGCGU---CAUCCGCU-AAGGACAAGAAGAAAAUCG--AAUAGCGUGUG   1  
II_11  ----------GAGGGUG---GAUACGU--GUAUGCGG---UUACAUCU-GUGGUUUCUAAAAGAGCAA--GCCGAUGUG--   1 
II_35* ----------GUGGGAA---GAUACGU--GUAUACGC---UAACAUAC-GGCAAGGUGAGUAGCCGGA--AGUAGCAUGUG   3 
II_08  -------------AGUGGAAGUUAUGU--GUAUGCGGUA--GAUAGGUAACGUUCUGUCAUAGGAAGGU-ACUAUCGU---   1 
II_30  -------------AGUGGAAGUUAUGU--GUAUACGC----GAAAAGUAUCAUUCC-UCAAACAGGGGC-GAUAACGCGAG   1 
II_16* ---------GCCGAGUGGGGACUUUAU--CUCAAGGGC---GCCAAACGUUGGGGC--UGGAGGACGGA-GAUAGCG----   2 
II_12  ---------GUGCUGCGG--GCCGUUC--AUAGUGGACG-GGGUAGACAGAGAACC-UUAGACCAAGGU-AUCGGC-----   1 
II_13  ---------CUGAUGUGAU-GGCCUUG--GUCGAAGCGG-GAUCCGACAGCUA-CU-AUAGAG-GUGUU-GUCGAGG----   1 
II_24  CCUGAGAGCGUAAUGUGACGGACAGUC--GCACUGGAGG-AGGAGGA-AGUGAUGC-AUCGAUCG----------------   1 
II_46b -------------CCUGAGGUUGGAUGAGCCA-GCAUCG-UAACAAACCUUCGGUG--AGAAGAGCGGC-AACUUUAUG--   1 
II_48  ----------CCGUUUGUAAGAUGAUGGGCCG-A-AGCU-AGACAGGGGUGUGGCU--U-AAGAGCGG---GUUUGAGG--   1 
II_02b ------------------AUAUGGAUGAGCCAUAGCUCG-GAAAACGGAAGCAAUUCCUGAAGGGCAAAGAGCGGCGUG--   1 
II_22  ---------GAAAUGUACAUGGCGUUAAAGUAGACGCAG-GAUUAAGUGUGCUG-U---GGAGU-CGA--AAC--GCGG--   1 
II_38  --------CAGUACGUG-AUAGC-UUAGAG-AGACG----GAUUUAAAACAAGG-U---AGAGGGCGA--ACCUGGCGGCG   1 
II_07  ----------AGAUGGAAGUACCUUUGAACUGGGGG--A-GAAUGGUUAUGAGAAU---CUAG--CGA--AGCCGGAGGU-   1 
II_06  ----------------CGGUGGCGCAGACAGAUUUCCAGUAUGGCACGGACCGGAGAGGGAAGGA-UGACAGACGUG----   1 
II_21  ------------------UUGCCAC-GCUGGAUCUUCGGCGGAAGAGCCAUUCUAGGCGUAACAACUCAGAAAAGUGCG--   1 
II_23  --------------GGAUGGGCCAACGGCGAGC-GUCGAAGGAGC--UUAGUACCGAAGCAACGC--AAGCGUAGAGCG--   1 
II_39  --------------GGAUGGGCCACCA--AAGC-ACCGAAGGGUA--GGAGCCACUAACUUGCGGUGAAUGGAAGAGCG--   1 
II_20  --------------GGAUGGGCCACAACGGAUCAGACGACAGGCA--UU--CUUUGAAGGAAAGAU-CCCAGCAGAGCG--   1 
II_47  ----------GGCGGGAUGAGCCA------AGCAAUCCA-GGAGC--UAAACAGUCCAGUGAUUGUUCAGUGCGGC-CGU-   1 
II_33  -------------GCCGA-AAUG---GGAGGGGUGGCGUUAA--CCGGCAAAGCUGCACGGGCGAUGAAGAAACGCGGG--   1 
II_41  -------------UCCGACAGUG---GGGUGGGGGGCAGCAGGGCGAACAGGAAUGUACAAG--AUUGACCAACGGGG---   1 
II_14  ---------------CAAUAGUUCCCAGAGGGGGAGAGGCGCU-UAAGCAAG-CCGGAGAGG--AACAGGAACUGGGGG--   1 
II_25* -------CGAAGCCA-GCCGGCG--AUUGGGAACGACGGAAUUCC--UCACUUCUG--UUAAAGGUCAACCAGG-------   2 
II_44  -------------UA-GGCAGCG--GCGAGGGAAGUUGGAGCUUAGACCAGUUAGGAGCUGGAGACCAGGCAGUCG-----   1 
II_18  -------------UAUGUGAGCA--ACAGUGGA-GUCCUCAUUUGU-GGAGCUCCG--CAGAGGAUCCAUCAGGGGGUG--   1 
 
 
B 
 
II_14  CAAUAGUUCCCAGAGGGGGAGAGGCGCUUAAGCAAGCCGGAGAGGAACAGGAACUGGGGG 
 
His site: 5′ R A A G U G G G K K N(0-36) A U G U N(0-2) A G K A A C A G 3′ 
 
 
 
Fig. V-6.  Cloned sequences from Selection II.  A: Alignment of RNA variable region.  
Sequences aligned using emma (EMBOSS explorer).  Sequences with asterisks were found in 
more than one clone.  B: Clone 14 may contain the canonical His site.  Module 1 of His motif is 
highlighted in gray, Module 2 in black. 
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Individual clone binding characteristics 
Testing of individual clones from Selection II revealed that one RNA sequence, clone 44, 
binds phenylalanine as well as His-Phe, but does not bind histidine (Fig. V-7).  This 
characteristic was likely suppressed in the column chromatography analysis of pool RNAs from 
Selection II (Fig. V-2B), due to the relatively low number of clone 44 sequences in the pool.   
 None of the other tested clone RNAs from Selection II appeared to bind His, Phe, or 
equimolar His and Phe, as measured by elution from a His-Phe column, though most bound the 
dipeptide (Fig. V-8A).  This does not exclude the possibility, however, that the RNAs might bind 
the individual amino acids with relatively low affinity (too low to compete against the His-Phe 
on the column).  Therefore, several clones were chosen for calculation of KD for His, Phe, His-
Phe, and the related dipeptides His-Gly and Gly-Phe. 
 To get an estimate of which RNAs would have the lowest KD for His-Phe, and thus 
which would be most amenable to analysis, I plotted the maximum peak values (%) of  RNA 
elution from His-Phe columns upon addition of His-Phe from Fig. V-8A (Fig. V-8B).  RNAs 
with the highest peaks should have relatively low KD.  I also wanted to test RNAs with unique 
sequences (based on alignment), to see if very different sequences could have the same 
characteristics.  Based on this analysis, I chose clones 16, 40, and 25.  In addition, I decided to 
test clones 7 and 8, since their sequences are similar to clone 40 (Fig. V-6), but the KD for clone 
7 in particular appears to be higher. 
KDs were then determined by isocratic elution from His-Phe-sepharose columns as in 
(Ciesiolka et al. 1996) (Table V-2).  Clones 16, 25, and 40 have KDs less than 100 µM for His-
Phe; these values are comparable to the measured KD for the previously characterized His 
aptamer, 8-54 µM (Majerfeld et al. 2005).  Clones 7 and 8 have higher KDs, as was expected for  
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Fig. V-7.  Clone 44 elutes from His-Phe column upon addition of Phe, but not His.  A: Phe 
elution.  B: His elution.  1.5 mM His, Phe, or His-Phe in column buffer were applied to the 
column where indicated. 
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Fig. V-8.  Binding characteristics of clones from Selection II.  A: elution profiles of RNA 
clones 1, 6, 7, 8, 11, 12, 13, 16, 20, 22, 23, 24, 25, 33, 35, 39, 40, and 48 from His-Phe column.  
1.5 mM His, Phe, His and Phe, or His-Phe dipeptide in column buffer were added where 
indicated.  B: quantitation of peak maxima upon addition of His-Phe for selected clones.. 
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clone 7, but not necessarily clone 8 (Fig. V-8B).  However, the measurements for these two 
clones have relatively high errors, and so these estimates are less reliable. 
 
 His-Phe His Phe His-Gly Gly-Phe 
Clone 7 478 ± 61 µM >119 mM 22 mM 10.5 mM 31.6 mM 
Clone 8 102 ± 33 µM > 34 mM > 34 mM 5.4 mM > 34 mM 
Clone 16 87 ± 3 µM 13 mM 100 mM 17 mM > 587 mM
Clone 25 36 ± 2 µM > 727 mM > 727 mM 8.2 mM > 727 mM
Clone 40 77 ± 7 µM > 227 mM > 227 mM 3.4 mM 9.3 mM 
 
Table V-2.  Binding constants (KD) measured for His-Phe aptamers.  KDs are shown for 
specified ligands. 
 
 Even though the addition of His and Phe individually did not produce a clear elution peak 
for most clones (Fig. V-8A), direct analysis of KD for His, Phe and related dipeptides offers some 
insight into the binding characteristics of the His-Phe aptamers.  For example, Table V-2 shows 
that clone 16 does, in fact, have some affinity for His and Phe individually, though those binding 
constants are higher than those for the dipeptide His-Phe.  In addition, all the clones tested here 
have at least some measurable affinity for one of the His-Phe dipeptide derivatives, His-Gly 
and/or Gly-Phe.  In cases where this KD is lower than that for His or Phe, some or all of the 
peptide bond may be interacting with the RNA binding site.   
Structural analysis of selected clones 
Chemical probing using N-methylisatoic anhydride (NMIA), which reacts with 2′-OH of 
unpaired nucleotides, was performed for clones 8, 16, 25, and 40 (Fig. V-9, Fig. V-10).  In 
general, bases modified by NMIA correspond with unpaired bases in two-dimensional structures 
predicted by BayesFold (Knight et al. 2004).   
114 
 
Fig. V-9.  Chemical probing analysis of RNA 8.  Lanes on left of sequencing lanes are from 
protection experiments; on right, from modification/interference experiments.  Experimental 
lanes are exactly one nucleotide shorter than sequencing lanes.  Nucleotides implicated in 
binding are labeled beside gel (see Fig. 5.10 for interpretation; also for results of experiments 
with clones 16, 25, and 40).  Unbound 1, Unbound 2 = respective unbound fractions from 
NMIA-modified RNA passed through His-Phe-sepharose column; Bound 1, Bound 2 = 
respective fractions which eluted upon addition of 1.5 mM His-Phe to column.  Gel by D. 
Puthenvedu. 
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Fig. V-10.  Predicted RNA two-dimensional structures with results of chemical probing 
experiments.  Two-dimensional structures predicted by Bayesfold, using minimum free energy 
parameters.  Grey = primer nucleotides; White = NMIA-modified nucleotides.  Triangles = 
NMIA-modification protection by His-Phe; squares = modification enhancement by His-Phe; 
stars = binding interference upon modification; circles = binding enhancement upon 
modification.  Roman numerals indicate possible binding motifs. 
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Protection and binding enhancement/interference experiments revealed nucleotides which 
may be important for binding to His-Phe.  In particular, bases which are protected from 
modification while incubated with His-Phe, or bases which, once modified, prevent binding to 
His-Phe are candidates for direct interaction with the dipeptide (Fig. V-10).  However, the 
behavior of these bases may also be explained by induced structural changes from binding 
elsewhere on the RNA.   
Although the four clones tested do not share obvious sequence similarity from alignment 
(Fig. V-6A), chemical probing analysis reveals several common motifs which may be important 
for binding to His-Phe.  Clones 8 and 16 share the sequence AGUGG (with most of these 
nucleotides implicated in binding) in a loop immediately adjacent to a 4-6 bp stem (Motif I, Fig. 
V-10).  Clones 16 and 25 share an AGG(A/U)C motif (Motif III) in similar loop structures, and 
clones 8 and 40 share a relatively long sequence of GUAGAUA (Motif IV).  The structure of this 
sequence, however, does not appear to be the same between the two clones; part of the structure 
in RNA 8 is in a stem, which may explain why its KD is higher than that for RNA 40.  Finally, all 
four clones share the sequence AAG (Motif II) in a loop, in 3/4 cases directly adjacent to a stem, 
and with all nucleotides implicated in binding in all cases. 
In general, the clones have two or more loops, separated by stems, with loop (and some 
stem) bases implicated in binding to His-Phe (Fig. V-10).  The fact that so much of the structure 
of the variable region appears to be participating in binding is perhaps not surprising, since the 
ligand used here is larger than those used in previous studies involving amino acid aptamers.   
Peptidyl transferase assay 
 One of the aims of this study was to isolate RNA that would catalyze peptide bond 
formation between two activated amino acids.  Since most of the clone sequences which 
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emerged from Selection II bind His-Phe, and with varying degrees of affinity (hence possibly 
allowing for stabilization of the transition state for peptide bond formation), they were tested for 
inherent peptidyl transferase activity.  Clone RNAs were incubated with methyl esters of 
histidine and phenylalanine for 48 days in column buffer at 4o C (Scheme V-1).  Reactions were 
then treated with sodium hydroxide to hydrolyze RNA and methyl esters, purified through a C18 
cartridge, and derivatized with phenylisothiocyanate for liquid chromatography-mass 
spectrometry (LC-MS) analysis (Fig. V-11). 
 LC-MS analysis of a derivatized His-Phe standard revealed a peak with a retention time 
of 36.65 minutes which bears the characteristic signature of two mass values: one at m/z = 438, 
and one at m/z = 273 (Fig. V-12).  These masses correspond to the parent molecule PTC-His-
Phe, and its fragment PTC-His, respectively (Fig. V-11); thus a compound eluting with the same 
ion signature and at approximately 37 minutes is likely derivatized His-Phe.   
LC-MS analysis of reactions of His and Phe methyl esters with RNA clones revealed 
peaks with similar retention times and mass values to the standard; data from an experiment with 
RNA clone 21 is shown as an example (Fig. V-13).  This reaction results in a low-intensity peak 
with the same mass signature as PTC-His-Phe (only visible after extraction of ions 438 and 273 
from the chromatogram) at 36.8 minutes.  An even less intense peak is observed from a control 
experiment with His and Phe methyl esters incubated without RNA, which implies a low level of 
spontaneous dipeptide formation (Fig. V-14). 
Quantitation of peak areas for m/z = 438 and 273 (which correspond linearly with 
dipeptide concentration at picomolar levels for PTC-His-Phe standard) for reactions with clone 
RNA, random RNA and no RNA indicate a possible increase in the level of dipeptide formation 
in the presence of some clone RNA sequences (Fig. V-15).  However, these data were not  
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Scheme V-1.  Predicted reaction scheme for peptidyl transferase assay.  Histidine methyl 
ester A and phenylalanine methyl ester B may react with RNA to result in His-Phe methyl ester 
C.  This is treated with sodium hydroxide to result in His-Phe D, which is then purified through a 
C18 column and derivatized.
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Fig. V-11.  Derivatization and structures of mass spectrometry products.  
Phenylisothiocyanate A and His-Phe B react with RNA to result in PTC-His-Phe C.  This is 
protonated during mass spectrometry, and also fragmented to result in PTC-His fragment D. 
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Fig. V-12.  LC-MS chromatogram of PTC-His-Phe standard.  A: chromatogram of all masses 
detected, with highest intensity m/z indicated at peaks.  Arrow indicates PTC-His-Phe.  B: 
extracted ion 273 intensity from chromatogram.  C: extracted ion 438 intensity from 
chromatogram.  Numbers above peaks in B, C indicate elution time.
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Fig V-13.  LC-MS chromatogram of clone 21 peptidyl transferase experiment.  A: 
chromatogram of all masses detected, with highest intensity m/z indicated at peaks.   B: extracted 
ion 273 intensity from chromatogram.  C: extracted ion 438 intensity from chromatogram.  
Numbers above peaks in B, C indicate elution time.  Arrows in B, C indicate estimated PTC-
His-Phe peaks. 
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Fig. V-14.  LC-MS chromatogram of  control peptidyl transferase experiment without 
RNA.  A: chromatogram of all masses detected, with highest intensity m/z indicated at peaks.   
B: extracted ion 273 intensity from chromatogram.  C: extracted ion 438 intensity from 
chromatogram.  Numbers above peaks in B, C indicate elution time.  Arrows in B, C indicate 
estimated PTC-His-Phe peaks. 
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reproducible due to the high noise present in the LC-MS chromatograms for test reactions 
(compare Figs. V-13, V-14 to Fig. V-12), day-to-day variation in the sensitivity of the mass 
spectrometer (which cannot be quantitated without incorporation of an internal standard), and 
possible inconsistencies in derivatization and purification.  These issues will need to be 
addressed and corrected before it can be determined whether or not His-Phe-binding RNAs also 
catalyze peptide bond formation. 
 
Discussion 
The RNA sequences which emerged from Selection II bind His-Phe, but nevertheless 
have varying characteristics.  Firstly, even RNAs with similar KDs have quite different 
sequences, and also have different secondary structures and possible binding motifs.  Varying 
RNA affinities for the individual amino acids as well as related dipeptides indicate that some of 
these sequences may bind different parts of the His-Phe dipeptide with high affinity, though very 
few of them appear to bind one amino acid exclusively.  RNA 16, in particular, has measurable 
affinity for both the individual amino acids and for the dipeptide, which was the goal of the 
selection.   
It seems likely, then, that RNA could bind two activated amino acids simultaneously, and 
bring them together into the correct orientation for peptide bond formation to occur.  This 
mechanism may parallel that of the ribosome, which mostly functions to position tRNAs and 
their respective amino acids in a conformation favorable for peptidyl transferase (Sievers et al. 
2004).  Since the 2′-OH of the aminoacyl substrate may catalyze extant peptide bond formation 
(Weinger et al. 2004), it may be worthwhile to repeat peptidyl transferase experiments using His-
Phe aptamers and amino acids activated as 2′/3′ esters of ribose or nucleotides. 
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Methods 
Column synthesis 
To synthesize His-Phe-sepharose columns, 100 µmol sepharose was first dried in N,N-
dimethylformamide (DMF).  33 µmol Fmoc-Phe-OPfp (Novabiochem) in DMF and 66 µmol 
N,N-diisopropylethylamine (DIPEA) were added, and the solution was mixed for 120 min.  
Sepharose was washed with DMF, and the column was acetylated with 3 mmol acetic anhydride 
+ 3 mmol DIPEA for 60 min.  Fmoc was then removed by the addition of 20% piperidine in 
DMF.  Fmoc-His-Fmoc-OPfp (Bachem; 400 µmol in DMF) and 800 µmol DIPEA were then 
added, and the column was mixed for 4 hrs.  The column was again acetylated, and Fmoc was 
removed from His by addition of 20% piperidine in DMF.  Concentration of His-Phe was 
calculated by measuring OD301 of piperidine/DMF fractions to calculate the amount of Fmoc 
eluted from the column.  Final His-Phe concentration = 1.6 mM.  Column was washed and stored 
in water. 
Library synthesis 
Single-stranded DNA was ordered from IDT.  BR sequence: 5′-
GGCAAGTACTCTGACGC(60N)GCGTAGAGGAGGACAGCG-3′.  3′-primer sequence, 3′ 
DIP:  5′- CGCTGTCCTCCTCTACGC-3′.  5′-primer sequence, T7 DIP: 5′- 
TAATACGACTCACTATAGGCAAGTACTCTGACGC-3′, where the underlined nucleotides 
indicate the T7 promoter. 
Single-stranded DNA BR was converted to double-stranded DNA using PCR.  PCR 
conditions: 1X Taq buffer (Promega), 0.41 mM dNTPs, 4.4 mM MgCl2, 4.5 µM each primer, 
0.45 µM BR DNA, 0.046 units/µl Taq polymerase (Promega).  Cycles: 94o C for 5 min; *94o C 
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for 30 sec, 50o C for 30 sec, 72o C for 2 min; repeat from “*” 5 times; 72o C for 7 min.  
Amplified DNA was ethanol-precipitated and resuspended in water. 
RNA was transcribed from dsDNA as follows: 1X T7 Flash buffer (Epicentre), 7.5 mM 
NTPs, 10 mM DTT, 0.125-0.25 (1.5 mCi/mL) α-32P-GTP or CTP, 1-10 µM DNA, 1X T7 Flash 
enzyme (Epicentre).  Incubation was at 37o C overnight.  Transcription was then treated with 
DNase I (Epicentre), gel purified, and ethanol precipitated. 
Selection 
Prior to column affinity chromatography, 32P-labeled RNA was folded by heating at 65o 
C for 3 minutes, adding 5X column buffer to a final concentration of 1X (50 mM HEPES pH 7.0, 
600 mM NaCl, 5 mM MgCl2, 5 mM CaCl2), and reheating for 30 seconds.  Each cycle (except 
for Cycle 1) was preceded by a counter-selection against RNAs that nonspecifically bound to 
acetylated sepharose.  RNAs (1 nmol for Cycle 1) were then applied to His-Phe-sepharose 
columns (equilibrated with 8 column volumes column buffer) and eluted with either 1.5 mM His, 
1.5 mM Phe, or 1.5 mM His-Phe in column buffer.  For Selection II, His and Phe were applied 
individually to the column and the eluted RNAs were discarded, prior to the addition of His-Phe 
to the column.  Columns were then washed with high salt buffer: 50 mM HEPES pH 7.0, 1 M 
NaCl, 2 mM EDTA.  Desired fractions were pooled, precipitated, and reverse transcribed into 
DNA using AMV reverse transcriptase (Life Sciences, Inc.).  ssDNA was amplified by PCR (as 
for library amplification), and the cycles were repeated until a significant fraction of the RNA (as 
measured by scintillation counting) was shown to elute from His-Phe columns upon addition of 
His-Phe.  This RNA was cloned (Novagen PT7 Blue-3 Perfectly Blunt Cloning Kit) and 
sequenced by Sanger sequencing. 
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Chemical probing 
 RNA was folded as previously but with the addition of 5.5X SHAPE folding buffer to 1X 
(final 50 mM HEPES pH 7.5, 400 mM NaCl, 5 mM MgCl2, 5 mM CaCl2).  Modification of 
RNA by N-methylisatoic anhydride (NMIA) was carried out as in (Wilkinson et al. 2006), using 
13 mM NMIA and incubating at 24o C for 155 minutes, or 37o C for 45 minutes.  Protection 
experiments used ~1 pmol RNA; RNA, His-Phe and NMIA were incubated as in modification 
experiments.  For binding interference/enhancement experiments, 32P-labeled RNA was NMIA-
modified, passed through a Micro Bio-Spin 6 chromatography column (Bio-Rad) exchanged 
with column buffer, and subjected to affinity chromatography through a His-Phe-sepharose 
column.  Unbound fractions followed by fractions eluted upon addition of 1.5 mM His-Phe were 
collected, ethanol-precipitated, and reverse transcribed for PAGE analysis.  PAGE used 8% 
acrylamide/7M urea in TBE, run at 1600 volts until xylene cyanol had migrated 16.5 cm. 
Peptidyl transferase assay 
 Individual RNA clones (1 µM) were folded as previously and then incubated in column 
buffer with histidine methyl ester  (1 mM) and phenylalanine methyl ester (1 mM; total volume = 
100 µl) for 48 days at 4o C.  Once reactions were completed, RNA and methyl esters were 
hydrolyzed by incubating reactions in 50 mM NaOH at 85o C for 10 minutes, followed by 
addition of MOPS pH 6.5 to 50 mM.  Samples were then purified through a Waters Sep-Pak® 
C18 cartridge (water wash, methanol elution) and methanol fractions were pooled and 
evaporated with a Speed-vac.  Elution of a His-Phe standard from C18 Sep-pak was confirmed 
by thin layer chromatography on a silica gel 60 F254 TLC sheet (EMD) using  3:1:1 
isobutanol:glacial acetic acid:H2O and ninhydrin staining. 
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 Samples were then derivatized by adding 20 µl phenylisothiocyanate and 400 µl coupling 
buffer (10:5:2:3 acetonitrile:pyridine:triethylamine:H2O) (Heinrikson and Meredith 1984).  
Reaction was for 10 minutes at room temperature, and was followed by evaporation of solvent 
with a Speed-vac.  Samples were dissolved in 10% acetonitrile/0.1% formic acid directly prior to 
mass spectrometric analysis. 
Liquid chromatography-mass spectrometry 
 Derivatized samples were subjected to liquid chromatography-mass spectrometry (LC-
MS).  LC was carried out with a Jupiter 5 µM C18 column, 0.25 mm  x 140 mm with a 300 Å 
resin (Phenomenex).  Gradient was 95% A/5% B for 5 minutes, ramp to 100% B for 20 minutes, 
hold for 5 minutes, ramp to 95% A/5% B for 5 minutes, hold for 10 minutes.  Solvent A = 0.1% 
formic acid in water; solvent B = 80% methanol and 0.1% formic acid in water. 
 Mass spectrometric analysis was performed with an electrospray (ESI)-triple quadrupole-
time-of-flight (qTOF) mass spectrometer from Applied Biosystems (PE SCIEX/ABI API 
QSTAR Pulsar I Hybrid LC/MS/MS) in the ESI + mode (high voltage = 4800 V). 
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CHAPTER VI  
CONCLUSION 
 
Small RNA-amino acid interactions 
In this work I have demonstrated that small RNAs and amino acids interact in 
ways previously thought improbable, and that small RNAs may have played a role in the 
origin of protein synthesis.   
The ribozyme GUGGC acts in trans to acylate a substrate RNA (GCCU), just as 
transfer RNAs are acylated in the modern translation system.  Once aminoacyl-RNA 
products are formed, they are extended to peptidyl-RNAs, which may have played a role 
in early biology; for example, the synthesis of relatively short, random peptides may have 
been necessary before the evolution of coded protein synthesis.  GUGGC also catalyzes 
the formation of aminoacyl-RNA diesters, which are more stable than monoesters, and 
thus may have been substrates for peptide synthesis even in unstable conditions. 
The existence of productive RNAs at a time when RNA synthesis was likely 
relatively inefficient is now plausible.  The GUGGC/GCCU complex is only comprised 
of nine nucleotides (with six of the bases free to vary, as long as they form a 3-base pair 
stem), and yet results in the formation of at least twenty biologically relevant products 
when reacted with PheAMP.  Thus, only 18 bits of information are required to generate a 
variety of biological compounds (Legiewicz and Yarus 2005).  Even random synthesis of 
short RNAs  should result in not only the ribozyme characterized here, but possibly 
others with similar capabilities. 
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This ribozyme is able to react with at least two different activated amino acids, 
and presumably more.  This observation, combined with the fact that the base pairing 
nucleotides in the enzyme-substrate complex are free to vary without abolishing activity 
(Illangasekare and Yarus 2010), indicates that more structure would be needed for the 
RNA complex to react specifically with a particular amino acid.  The coding coenzyme 
handle hypothesis proposes that the first aminoacyl-RNA adaptors (proto-tRNAs) were 
trinucleotides which first bound selectively to their respective amino acids (Szathmary 
1993); the data shown here indicate that three nucleotides alone may not be enough to 
confer specificity to a particular amino acid. 
 I have also demonstrated here that RNA can bind a dipeptide with high affinity 
and discrimination.  The binding characteristics of most of the selected RNAs indicate 
that they are interacting with both amino acids simultaneously, since they display higher 
affinity for the His-Phe dipeptide than for either of the individual amino acids.  This 
supports the Direct RNA Template hypothesis, which first requires the existence of RNA 
which will bind two amino acids in close proximity to each other (Yarus 1998, Yarus et 
al. 2009). 
 While it remains to be seen whether or not His-Phe aptamers can catalyze peptide 
bond formation (the next step in the DRT model), the characteristics of selected dipeptide 
aptamers are promising.  Since these RNAs have a range of affinities for the dipeptide, 
and are quite varied in their sequences, it seems possible that some of them may be able 
to stabilize the transition state for peptide bond formation between activated His and Phe, 
thus catalyzing peptidyl transfer.  Aptamers with the highest affinity for His-Phe may not 
be good catalysts for peptidyl transferase, in part due to product inhibition (once the 
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product is formed, it will remain bound to the RNA, inhibiting the reaction), but catalytic 
variants of these aptamers may have arisen through mutation (which can be tested 
experimentally), thus fulfilling the second step of DRT. 
 
Model for the origin of translation 
 The RNA-amino acid interactions described in this work can be used to generate a 
model, which, when combined with DRT, describes how protein synthesis may have 
originated (Fig. VI-1).  In the first part of the model, RNA-dipeptides are formed from 
small RNA enzyme/substrate complexes (such as GUGGC/GCCU) and activated amino  
acids, as has been demonstrated experimentally.  While this work has only described the 
synthesis of RNA-peptides using one amino acid (RNA-Phe-Phe), RNA-X-Y synthesis 
should be possible, where X and Y are different amino acids, since peptide bond 
formation in this case is spontaneous, but dependent on RNA for formation of the initial 
aminoacyl-RNA and the accompanying increase in nucleophilicity of the esterified amino 
acid.  In addition, since GUGGC/GCCU can tolerate variable acylation substrates, the 
dipeptides generated from this reaction should be random. 
 Once RNA-dipeptides are formed, the dipeptides could either (A) hydrolyze at 
ester bonds to become free in solution, or (B) remain bound to the RNA (Fig. VI-1).  In 
mechanism (A), free dipeptides may then encounter RNA molecules; if the RNA 
sequence allows it to bind the dipeptide, it may become itself stabilized and have a 
selective advantage.  In mechanism (B), since dipeptides remain esterified to RNA, their 
recruitment to dipeptide-binding RNAs may be accelerated due to base pairing  
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Fig. VI-1.  Model for early translation evolution, incorporating tiny acylators and 
dipeptide aptamers.  First, a ribozyme acylates an RNA substrate with amino acid 1 
(circle), as in GUGGC/GCCU.  Aminoacyl-RNA can then react with activated amino 
acid 2 to form peptidyl-RNA.  This can hydrolyze (A) to leave free dipeptide, which can 
then bind to a dipeptide aptamer (one form of proto-DRT).  In mechanism (B), RNA-
peptides bind directly to dipeptide aptamers. 
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interactions between the two RNAs.  No matter which mechanism occurs (and they are 
not mutually exclusive), the final product is an RNA aptamer bound to a dipeptide.   
The dipeptide-binding RNA, which can be termed “proto-DRT,” could then 
evolve, if needed, to accommodate binding of two carboxyl-esterified amino acids, as in 
the DRT model, and eventually to catalyze peptide bond formation.  Binding of these 
aminoacyl esters to the DRT could also be facilitated by base pairing. 
 Mechanism (B) in particular offers a possible scenario for the emergence of 
tRNA.  GUGGC’s RNA substrate ends with (and is acylated at) the sequence “CCU,” 
which is similar to the sequence found at the end of all tRNAs, “CCA.”  This suggests 
that tRNAs may have evolved from something like GCCU.  Short substrate RNAs 
esterified to amino acids would eventually have had to evolve and become more specific 
for particular amino acids.  Therefore, as dipeptide-binding RNAs were evolving to 
catalyze peptide bond formation, short substrate RNAs must have evolved to be more 
selective for their substrates.  This could have arisen from interactions between substrate 
RNA (proto-tRNA) and codons associated with the hemiDRT and riboribosome (proto-
ribosome), as proposed in DRT (Yarus et al. 2009). 
 To summarize, this model predicts an initial phase of random, short peptide (and 
RNA-peptide) generation, which could aid in the evolution of specific, coded peptide 
synthesis. 
 
Future directions 
 Future studies with both the tiny acylator and dipeptide-binding RNA will help us 
to even better understand the potential for RNA catalysis in the origin of translation.  
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Since our model requires ribozymes to interact with activated amino acids (here in the 
form of acyl adenylate) for acylation, possible sources of activated amino acids should be 
investigated.  Firstly, GUGGC/GCCU could be reacted with the self-activating ribozyme 
(Kumar and Yarus 2001) and phenylalanine.  This ribozyme forms a phosphoric 
anhydride linkage between an amino acid and its own 5′-terminal guanosine, which is the 
same method of activation as in acyl adenylates.  GUGGC/GCCU may be able to use this 
activated amino acid as a substrate for acylation; however, since the activating ribozyme 
requires acidic conditions, optimal conditions for both reactions would have to be 
determined, or cyclic conditions could be used. 
 Alternatively, GUGGC/GCCU may be able to react with amino acids activated in 
another manner.  Since the complex has been shown to react with PheUMP as well as 
PheAMP, it is apparent that different activating groups can be tolerated.  In addition, the 
model for the C3 ribozyme reaction only requires hydrogen bonds to form between RNA 
and the carboxyl, amino and phosphate groups of PheAMP.  Therefore, GUGGC/GCCU 
may be active with substrates as simple as acyl phosphates, which may have been easier 
to synthesize than acyl adenylates in the RNA world. 
 Random peptide synthesis, as catalyzed by RNA, can also be investigated.  Since 
GUGGC/GCCU reacts with MetAMP (and, by extension, may be able to acylate with 
many different amino acids), and subsequent peptide bond formation is spontaneous (and 
likely not dependent on the side chain of the amino acid), presumably most any 
combination of amino acids could react to form a variety of RNA-peptides.  It would be 
interesting to see if this is indeed the case, and if certain amino acids are more prone to 
acylation/polymerization than others. 
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 Now that we know that tiny ribozymes exist, it would be worthwhile to 
investigate the capabilities of small RNAs even further.  Larger ribozymes that have been 
found through in vitro selection may be revisited, split into in trans complexes, and re-
assayed for activity.  It may be possible to isolate small populations of tiny RNAs, rather 
than large ribozymes, which work together to perform catalysis.  Alternatively, selections 
for activity could be done directly by using collections of tiny, random RNAs.  These 
could be selected by using microfluidics systems, which allow the user to select multiple-
turnover enzymes that function in trans (Tawfik and Griffiths 1998). 
 Further work can also be done to research dipeptide-binding RNA in the context 
of the RNA world.  The pool RNAs which emerged from the selection can be further 
characterized; for example, further testing may reveal more clones which bind to the 
individual amino acids as well as the dipeptide with measurable affinity (KD).  These 
would be promising candidates for peptidyl transferase ribozymes.   
In addition, the binding site(s) for His-Phe should be further characterized; this 
can be done not only with chemical probing of RNA clones, but also through high-
throughput analysis of pool RNAs which have been subjected to 454 sequencing.  This 
analysis may reveal His-Phe-binding sequence motifs, allowing us to better define the 
binding site(s).  Bioinformatics may also allow us to determine if there is a bias toward 
His and Phe codons and/or anticodons in the binding site, which may support the DRT 
model.  Further, defining which parts of the binding site bind His, and which bind Phe, 
may help us to determine if codons and anticodons emerged from direct stereochemical 
interactions between RNA and amino acids. 
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 Since it is not yet clear whether or not His-Phe aptamers can catalyze peptide 
bond formation, our assay should be refined, or a new assay should be developed to 
address this question.  LC-MS may be possible with non-derivatized dipeptides (which 
may require use of a different LC column and a different elution gradient), which would 
eliminate some of the purification and quantitation issues I experienced.  Using scaled-up 
reactions should also make quantitation more accurate. 
 However, if none of the aptamers behave as catalysts, a re-selection could be 
performed to find peptidyl transferase ribozymes.  His-Phe binding RNAs could be 
mutagenized to different extents, and also ligated to a stretch of random RNA, as well as 
to SS-His ribose ester (Fig. VI-2).  This complex can be reacted with a Phe-sepharose 
column, where Phe is attached to sepharose via a covalent amide linkage.  When His-SS-
RNA is applied to the column, one of two reactions may occur.  The first (desired) 
reaction is nucleophilic attack of the amino group of phenylalanine on the carboxyl group 
of histidine, forming a peptide bond (Product 1, Fig. VI-2).  The catalytic RNA will 
remain associated with the Phe-sepharose until it is released by reduction of the disulfide 
bond linking it to histidine.  This RNA can then be pooled and amplified for the next 
cycle. 
 The second reaction which may occur is attack of the carboxyl group of histidine 
by any internal 2′-OH of the ribose of RNA.  The product of this reaction would be a 
lariat structure (Product 2, Fig. VI-2) which would not associate with Phe-sepharose, and 
thus would not be hindered by the column.  RNA in this formation would flow directly 
through the column, and there would be minimal contamination of the desired RNA by 
these products.  Since the selection would start with RNA which has some affinity for  
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Fig. VI-2.  Re-selection for peptidyl transferase ribozymes.  Mechanism 1 represents 
the desired reaction of peptidyl transferase.  Reaction 2, ester transfer, may occur, but 
products will not be retained by the Phe-sepharose column.  The function of the random 
RNA region is to induce catalysis. 
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His-Phe, some of the side reactions which complicated earlier selections for peptidyl 
transferase ribozymes would be less likely to occur. 
 Further work on the RNAs characterized here may also be important for studies in 
extant biology.  Now that we know how to select RNAs that bind multiple amino acids 
(by eliminating RNAs that only bind individual amino acids), we could potentially select 
RNAs which bind tripeptides, tetrapeptides, and so on,  until the limit of efficient 
selection in this manner is determined. 
The extension of the dipeptide-binding RNAs to longer peptides would provide 
insight into the specific interactions between RNA and short peptide sequences.  This  
may be useful for designing aptamers that will bind to specific amino acid sequences in 
proteins.  Modern selections for protein aptamers do not select for RNAs that will bind a 
predetermined site in the protein (Daniels et al. 2003).  The selections described above 
could be used to isolate an RNA specific to a short amino acid sequence (either a pre-
existing, unique sequence in the protein or an artificial sequence that could be added to 
the protein).  This could allow for an efficient method for designing aptamers that would 
bind to predetermined sites of a protein, such as sites that would allow maximum 
interaction of a protein with its substrates.  Such an aptamer may be preferable to a 
monoclonal antibody for target identification, as it has been shown that many aptamers 
are more specific and bind with higher affinity than antibodies (Brody et al. 1999).   
Tiny, acylating RNAs may also be useful in studies of current biology.  A variant 
of GUGGC, for example, may be able to act in trans to acylate tRNA, using either 
canonical or non-canonical amino acids (Fig. VI-3).  This ribozyme would have to share 
at least three base pairs with the 3′ end of tRNA, leaving the terminal adenosine free to  
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Fig. VI-3.  Proposed reaction for tiny tRNA acylator.  The ribozyme resembles an 
early trans variant of the C3 ribozyme, but with a shortened stem and two changed 
nucleotides (circled).  This ribozyme may acylate a tRNA-like substrate when reacted 
with acyl adenylate. 
144 
react.  This means that the base opposite this A, which is normally a U in GUGGC and 
the C3 ribozyme (Chumachenko et al. 2009), would have to be mutated to avoid base 
pairing with A.  Mutation of this U to C in the C3 ribozyme did not abolish activity, and 
so it seems possible that the ribozyme depicted in Fig. VI-3 may be able to acylate a 
substrate which has the same terminal secondary structure as tRNA, and, once conditions 
are optimized, a real tRNA.   
Since the small ribozymes characterized here can react with variable aminoacyl 
substrates, and the only sites of recognition between the proposed ribozyme and tRNA 
are the last few bases of tRNA, any tRNA should be able to be acylated with a number of  
different amino acids.  This could be useful in studies investigating the effects of tRNA 
misacylation on translation.  Ribozymes which catalyze acylation of tRNA have been 
described previously (Lee and Suga 2001, Murakami et al. 2002).  However, these 
ribozymes require amino acids to be activated by non-biological leaving groups which 
are not water-soluble.  The ribozyme proposed here should react with PheAMP, which is 
water-soluble and easy to synthesize, making it ideal for in vitro studies with tRNA.  In 
addition, this ribozyme is relatively inexpensive due to its small size, and so more 
experiments could be done at a lower cost than with a larger RNA. 
In conclusion, it seems likely from this work that RNA played an important role 
in the origin of protein synthesis, and thus in the origin of life as we know it.  The RNA-
amino acid interactions characterized here offer a possible explanation of how complex 
molecules could have arisen from primitive conditions.  If we can understand how life 
may have originated, we will not only be better acquainted with the nature of life on 
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Earth, but we will be better equipped to answer the question of whether or not life could 
exist on other worlds. 
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